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Abstract 
Retinoic acid-inducible gene 1 (RIG-I) plays a major role in antiviral innate immunity by 
detecting cytoplasmic viral RNA and triggering the pathway that leads to transcriptional 
activation of type I interferon (IFN). Type I IFN induces a large set of genes called interferon-
stimulated genes (ISGs) that coordinate a response to antagonize viral invasion. We utilized 
single-molecule fluorescence in situ hybridization (smFISH) to study viral and antiviral gene 
expression in individual cells. We precisely quantified kinetics of mRNA expression of RIG-I 
with respect to IFN- in cells upon infection with Sendai virus (SeV). We found that RIG-I 
mRNA is directly induced by viral infection in the absence of IFN at the early stages of viral 
infection. High throughput screening of ISGs expression following viral infection revealed other 
genes, which we termed as “early genes”, induced via the IFN-independent mechanism. We 
found that this mechanism is dependent on interferon regulatory factor 7 (IRF7) and interferon 
regulatory factor 3 (IRF3). Simultaneous detection of mRNA of IFN-, viral L gene, and ISGs 
revealed distinct populations of IFN- expressing and non-expressing cells which are dependent 
on the early genes but are independent of other ISGs and the viral load. Single-cell analysis of 
IRF7/3- and NF-kB-dependent gene expression suggest that early IRF7/3-dependent gene 
expression may facilitate the activation of transcription factor NF-kB and contribute to the 
decision making process for IFN- production. 
Fluorescence microscopy is an essential tool in biology. However, fluorescence microscopy is 
limited by diffraction to a spatial resolution of >200 in lateral dimensions, and >500 nm in axial 
dimension, leaving many biological structures too small to study in detail. With the recent 
developments in super-resolution imaging techniques, the resolution limit of conventional 
fluorescence microscopy has been surpassed. One such technique is referred to as stochastic 
optical reconstruction microscopy (STORM), and provides ~ 20 nm lateral and ~ 50 nm axial 
resolution. We constructed a STORM microscope, and used it to image cellular localization of 
RIG-I in the virally infected cells. STORM imaging revealed clustering of RIG-I, that was not 
visible under conventional fluorescence microscope.   
iii 
 
One of the critical aspects of a virus life cycle is packaging of the viral genome. We studied 
packaging mechanism of Influenza A Virus (IAV). IAV possesses a segmented genome of eight, 
single-stranded RNAs. However, the exact copy number of each viral RNA segment per 
individual virus particle has been controversial for the past 50 years. To address this question, we 
combined single molecule TIRF microscopy and fluorescence in situ hybridization (FISH) to 
study the composition of viral RNAs at single-virus particle resolution. Our results showed that a 
high percentage of virus particles package a single copy of each segment of viral RNAs. Our 
findings support a model that the packaging of IAV genome is a selective and robust process.  
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Chapter 1 
Introduction 
Viruses are highly infectious pathogens that depend on host cells to survive and replicate. The 
innate immune response is the first line of defense against an invading virus. A key aspect of the 
antiviral innate immune response is the synthesis of type I interferons (IFN) which exhibit 
antiviral, anti-proliferative and immunomodulatory functions.  
 
Type I IFNs include several IFN- subtypes and a single IFN- subtype1. The activation of type 
I IFN genes is regulated at the transcription level and the mechanism is best understood for the 
IFN- promoter. A multi-protein complex called an enhanceosome is assembled at the IFN- 
promoter in response to a viral infection. The enhanceosome consists of three distinct sets of 
transcription factors; ATF-2/c- Jun, nuclear factor kappa-light-chain-enhancer of activated B 
cells (NF-B), interferon regulatory factor 3 (IRF3), interferon regulatory factor 7 (IRF7) and 
architectural protein HMGI(Y)
2, 3
. The activities of NF-B, IRF3 and IRF7 are regulated by their 
subcellular localization. In the uninfected cells, NF-B is localized to cytoplasm, inhibited by B 
(IB) family members. Upon infection, the IB kinase (IKK) is activated and then it 
phosphorylates IB. Once phosphorylated, IB is ubiquitinated and subsequently degraded. Free 
NF-B then translocates into the nucleus and turns on target genes4. Likewise, while localized to 
cytoplasm at the steady state, IRF3 and IRF7 are phosphorylated by the IKK-like kinases TBK1 
and IKK, causing IRF3 and IRF7 to form heterodimers, and translocate to nucleus upon viral 
infection
5,
 
6
. Viral infection activates signals that phosphorylate ATF2/c-Jun in the nucleus. 
Together with the nuclear architectural protein HMG-I (Y), NF-B, IRF3, IRF7 and ATF2/c-Jun 
assemble into the enhanceosome complex that remodels the chromatin in the promoter of IFN-, 
resulting in its transcriptional initiation.  
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Once produced and secreted, IFN- binds to the IFN-/ receptor (IFNAR) triggering the 
activation of the janus kinase (JAK) family members JAK1 and Tyk-2. These kinases 
phosphorylate and activate the signal transducer and activator of transcription 1 (STAT1) and 
STAT2 proteins. STAT proteins associate with IRF9 to form a complex called IFN-stimulated 
gene factor 3 (ISGF3), that initiates the transcription of several interferon stimulated genes 
(ISGs) by binding to the IFN-stimulated response elements (ISRE) in their promoter regions. The 
ISGs inhibit different stages of virus replication and establish an anti-viral state in the host
1
. 
 
In order to trigger an effective antiviral response, the invading virus has to be detected by the 
immune system receptors, which would then initiate signaling cascades to induce IFN 
production. Cells of the innate immune system detect molecular structures shared by various 
viruses, called pathogen-associated molecular patterns (PAMPs), through germline-encoded 
pattern recognition receptors (PRRs) present either on the cell surface or within distinct 
intracellular compartments. These include the Toll-like receptors (TLRs), the retinoic acid-
inducible gene I-like receptors (RLRs), the nucleotide oligomerization domain-like receptors 
(NLRs) and cytosolic DNA sensors.  
 
Of the PRRs, the TLRs are the most extensively studied. TLRs are type 1 transmembrane 
proteins that traffic between the plasma membrane and endosomal vesicles. The TLRs play an 
important role in sensing viral PAMPs that are present within the extracellular compartment, as 
well as in endosomes
7
.  Studies during the last decade or more revealed numerous other classes 
of sensors of innate immune system. Of particular importance to anti-viral defenses was the 
discovery of a specialized class of cytosolic nucleic acid sensors, termed RIG-I like receptors 
(RLRs), which recognize cytoplasmic RNA that is produced during viral infection
8, 9
. The RLRs 
consists of three DExD/H box RNA helicases; retinoic acid-inducible gene (RIG-I), melanoma 
differentiation-associated gene 5 (MDA-5), and laboratory of genetics and physiology-2 (LGP-
2). Both RIG-I and MDA-5 contain tandem N-terminal caspase activation and recruitment 
domains (CARDs) followed by a DExD/H box RNA helicase domain with ATPase activity and a 
C-terminal repressor domain (RD). Unlike RIG-I and MDA-5, LGP-2 lacks the N-terminal 
CARD domains, containing only the RNA helicase domain
10
.  
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RIG-I and MDA5 detect a variety of RNA viruses. RIG-I participates in the recognition of 
Paramyxoviruses (Newcastle disease virus (NDV), Sendai virus (SeV)), Rhabdoviruses 
(vesicular stomatitis virus (VSV)), Flaviviruses (hepatitis C (HCV)) and Orthomyxoviruses 
(Influenza), whereas MDA5 is associated with recognition of Picornaviruses 
(encephalomyocarditis virus (EMCV)
11
. The importance of the RIG-I pathway in antiviral 
immunity was confirmed with further research that show mice lacking RIG-I or MDA5 had 
dramatic phenotypes in vivo, and were found to be highly susceptible to respective viral 
infections. Knock down of RIG-I expression in  fibroblasts, epithelial cells, conventional 
dendritic cells and macrophages resulted in failure to activate type I IFN when these cells are 
infected with various RNA viruses, highlighting the indispensable antiviral role of RLRs in a 
broad range of cell types
12,
 
13,
 
14
. Furthermore, in a recent study, in which more than 380 human 
ISGs were screened for their ability to inhibit the replication of several clinically important 
human and animal viruses, RIG-I and MDA5 together with a few other ISGs, stood out with their 
strong antiviral activity against a broad range of viruses
15
. 
 
In the uninfected cells, RIG-I resides in the cytoplasm in an inactive form that is auto inhibited 
by its regulatory domain
16
. Upon viral infection, RIG-I undergoes a conformational change by 
which it dimerizes in an ATP dependent manner. The activated multimeric form of RIG-I and 
MDA5 then interacts with the downstream adaptor protein mitochondrial antiviral signaling 
protein (MAVS) (also known as VISA, IPS-1, and CARDIF), via CARD-CARD interactions on 
the outer mitochondrial membrane
17,
 
18, 19
 . Upon engagement of RIG-I or MDA5 with MAVS, 
MAVS activates cytosolic kinases IKK and TBK1, which activate the transcription factors NF-
B and IRF3, respectively. NF-B and IRF3 translocate into the nucleus, where they function 
cooperatively to induce type I IFN and other antiviral molecules
10
. 
 
RLR signaling pathway is tightly regulated. LGP2 was found to act as both a positive and 
negative regulator of RLR signaling, where its over expression enhanced ISG induction to a 
variety of viruses including SeV and NDV, and LGP2 knockout mice showed increased IFN 
responses and decreased susceptibility to VSV but not EMCV infection
20, 16
. E3 ubiquitin ligase 
TRIM25 positively regulates RIG-I activity through K63-linked ubiquitination at its N- 
terminus
21
. ZAPS was identified as a cofactor for RIG-I signaling
22
. ZAPS was shown to directly 
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associate with RIG-I in a ligand-dependent manner and to amplify downstream signaling events 
such as activation of the transcription factors IRF3 and NF-B and induction of type I IFN. As a 
result, ZAPS inhibited viral replication after infection with RIG-I-dependent viruses such as 
influenza virus or NDV. Mitochondrial outer membrane localizing NLRX1 was proposed to 
control RLR signal transduction by physically interrupting the virus-induced RLR–MAVS 
interaction
23
. STING (also known as MITA) was identified as a regulator of RIG-I signaling by 
directly binding to RIG-I, MAVS, and TBK1
24,
 
25
. Overexpression of the constitutively active 
fragment of RIG-I failed to induce IFN in STING-deficient mouse embryonic fibroblasts.  
 
All three receptors of the RLR family are cytosolic proteins, and they have not been found to be 
associated with any subcellular structure at steady state. Upon infection with IAV lacking NS1 
and transfection of poly I:C, RIG-I has been shown to form granular aggregates containing stress 
granule markers, termed antiviral stress granules (avSGs)
26
. avSGs are shown to be critical for 
activation of IFN suggesting that avSGs serve as a platform for detection of viral RNA. 
 
MAVS resides on the outer mitochondrial membrane, peroxisomes and MAMs, a specialized 
subdomain of the ER that connects mitochondria and peroxisomes
18,
 
17,
 
19, 27,
 
28
. Both 
peroxisomal and mitochondrial MAVS signal to induce ISG expression. While mitochondrial 
MAVS induces type I IFN and IFN-dependent ISG expression, peroxisomal MAVS directly 
induces ISG expression in the absence of IFN, which creates a transient yet functional antiviral 
state
27
.  While uniformly distributed on the mitochondrial membrane of the uninfected cells, 
MAVS is redistributed resulting in a speckle-like pattern on mitochondria upon viral infection. It 
has also been shown that a mitochondrial GTPase, Mitofusin 1 (MFN1), which regulates 
mitochondrial fission and fusion, plays a critical role in the redistribution of MAVS, as well as in 
virus-induced IFN production
29
. Recently it has been show that virus induced prion-like 
aggregates of MAVS is the active form of which propagates the antiviral signaling cascade
30
. 
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Chapter 2 
Analysis of Antiviral Gene Expression at 
the Single Cell Level
*
 
Introduction 
RIG-I-like receptors (RLRs) RIG-I, MDA5, and LGP2, constitute a family of cytoplasmic 
sensors of double-stranded RNA—a replication intermediate for RNA viruses1, 2. RLRs have 
indispensable roles in innate immunity
3-6
. Knockout mice that lack RIG-I or MDA5 had dramatic 
phenotypes in vivo, and were highly susceptible to infection by the respective RNA viruses
6
. 
Knock down of RIG-I expression in fibroblasts, epithelial cells, conventional dendritic cells, and 
macrophages results in failure to activate type I IFN when these cells are infected with various 
RNA viruses, highlighting the indispensable antiviral role of RLRs in a broad range of cell 
types
5
. Furthermore, a recent study screened more than 380 human ISGs for their ability to 
inhibit the replication of several clinically important human and animal viruses, and found that 
RIG-I and MDA5, together with a few other ISGs, stood out with their strong antiviral activity 
against a broad range of viruses
7
.  
Viral RNA bound to RIG-I (and possibly to MDA5) interacts with mitochondrial antiviral 
signaling protein (MAVS), also known as IPS-1, VISA or CARDIF, and activates transcription 
of type I interferon (IFN), which is among the earliest immune responses to viral infections
8-11
. 
IFN binds to the type I receptor (IFNAR) on the cell membrane and activates transcription of 
                                                          
*
 This work is in preparation for publication as: 
Doganay, S., Lee, MY., Baum, A., Peh, J., Hwang, SY., Yoo, JY., Hergenrother, P., García-Sastre, A., 
Myong, S., Ha, T. “IFN-independent expression of antiviral genes at the early stages of viral infection is a 
determinant of heterogeneous IFN- expression states.”  
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IFN-stimulated genes (ISGs) through the JAK-STAT pathway to establish an antiviral state and 
control infection
12-14
. In contrast to the general thought that RLRs induce type I IFN that in turn 
amplifies ISGs expression, it has also been shown that some ISGs, such as Viperin and ISG56, 
are induced directly by viral infection in the absence of IFN
15,37
. However, RLRs are known to 
be induced by type I IFN, and the kinetics of expression as a function of the infection stage (i.e. 
with respect to type I IFN production) has not been studied in detail.  
Moreover, most of the earlier works relied on bulk measurements from a large population of 
cells that might have masked some of the details of how IFN, RIG-I, and other ISGs are 
regulated in single cells upon viral infection. Some of the immune responses have already been 
shown to display cellular heterogeneity in gene expression
16-19
. For instance, the IFN- gene is 
shown to be expressed in a bimodal manner; after viral infection some cells activate the IFN- 
gene while others do not
16, 19
. This bimodality in IFN- expression is attributed mainly to the 
inherent complexity of IFN-activation mechanism that requires cooperative assembly of three 
distinct sets of transcription factors: NF-B, IRFs and ATF-2/cJun16, 19-21. In addition to the 
complexities at the transcription factor binding, several other upstream factors, such as viral 
replication level or other heterogeneity at the host gene expression levels may contribute to the 
decision making process of IFN- gene activation, depending on the cell type and the virus22-25. 
Therefore, bulk assays should be complemented with single cell measurements to obtain a more 
complete view of gene expression patterns associated with IFN- gene expression.  
In this study, we used single-molecule fluorescence in situ hybridization (smFISH) to quantify 
host and viral mRNA expression in individual cells
26, 27
. The single transcript sensitivity of 
smFISH makes it a reliable method for precise quantification of gene expression at the early 
stages of viral infection, when small changes in the expression level originating from a fraction 
of cells might not be accurately detected by other means. Our measurements of kinetics of RIG-I 
expression revealed an IFN-independent mechanism that is responsible for amplification of RIG-
I mRNA at the early stages of viral infection. This IFN-independent mechanism activates not 
only RIG-I, but also several other ISGs prior to IFN production, as shown by further screening of 
ISGs using smFISH and the Nanostring nCounter gene expression system
28
. We have shown by 
siRNA knockdown and immunofluorescence experiments that the process is dependent on 
interferon regulatory factor 7 (IRF7) and interferon regulatory factor 3 (IRF3). 
9 
 
Two distinct cell populations: IFN-expressing (IFN “on”) and non-IFN-expressing (IFN “off”) 
cells were observed in the smFISH assays.  We studied differential gene expression properties of 
these IFN “on” and “off” cells by counting transcripts of viral L gene, IFN-, and other host 
genes in single cells. The expression levels of RIG-I and several other early genes were highly 
correlated with IFN- expression. Furthermore, the early genes displayed a threshold for their 
number of transcripts that determined the IFN- expression states. On the other hand, viral L 
gene and other antiviral genes were largely uncorrelated with the heterogeneous IFN- 
expression states. Examination of transcription kinetics of IRF7/3-dependent and NF-B-
dependent genes in single cells showed that activation of transcription factor NF-B is more 
limiting, in the process of IFN-activation, than IRF7/3.  Furthermore, our results indicate that 
higher levels of IRF7/3-dependent genes may facilitate activation of transcription factor NF-B 
and thus contribute to the decision making process for IFN- production. 
Experimental Results 
Sensitive quantification of antiviral gene expression with single-cell resolution 
We performed smFISH experiments according to the protocol by Raj et al
27
. For each mRNA 
species, we designed 38 to 48 fluorescently labeled probes, each 20 bases long, complementary 
to the sequence of the target transcript (Fig. 1a). We hybridized probe mixes with fixed cells and 
imaged the cells under the fluorescence microscope. The sufficiently large number of 
fluorophores bound to a single mRNA yielded diffraction-limited fluorescent spots 
corresponding to single transcripts. smFISH assay also revealed the location and number of 
active RIG-I transcription sites in the nucleus as brighter fluorescent spots where mRNA 
molecules accumulated. For simultaneous detection of three different genes, we labeled our 
probes with spectrally distinguishable fluorophores (Cy3, Alexa Fluor 594, and Cy5) and imaged 
with the appropriate filter sets (Fig. 1a). In order to quantify the expression level of endogenous 
mRNA in individual cells, we counted the fluorescent spots from the 3D images of cells using 
software adapted from what was described by Raj et al
27
. As an example, here we demonstrate 
quantification of kinetics of IFN induced RIG-I expression. For this, we treated HepG2 cells with 
IFN- and fixed the cells at various time points. We then labeled mRNA of RIG-I and 
housekeeping gene ALAS
29
. Unstimulated cells displayed basal level of RIG-I mRNA, which is 
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on average ~30 transcripts per cell. Stimulating cells with IFN- changed the expression of RIG-
I in a time-dependent manner (Fig. 1b, c) whereas the expression level of housekeeping gene 
ALAS stayed relatively unchanged. Cytoplasmic RIG-I mRNA counts displayed a steep increase 
until 6 hours which was then followed by a plateau, with an average of above 200 transcripts per 
cell (Fig. 1c). 
RIG-I is directly induced at the early stages of viral infection independent of IFN signaling 
Having established the smFISH assay to quantify mRNA production kinetics, we set out to 
obtain a view of RIG-I expression following viral infection. Therefore, we infected clonal 
HepG2 cells with Sendai virus (SeV) and fixed the cells at various time points post infection.  
We then labeled RIG-I and IFN- mRNA, and screened 500 to 1000 cells for the expression of 
the two genes (Fig. 2). We detected IFN- mRNA earliest at 9 hours post infection (hpi) (Fig. 3a, 
b). Consistently, with ELISA, IFN- from the culture medium was not detectable before 9 hpi 
(Fig. 3c).  On the other hand, bright RIG-I transcription sites were visible in a small fraction of 
the cells as early as 3 hpi, several hours prior to IFN- production (Fig. 2, Fig. 3a, b). Percentage 
of cells expressing RIG-I mRNA reached 32% by 6 hpi with an average of ~145 transcripts per 
cell (Fig. 2b, d). The percentage of cells overexpressing RIG-I gradually rose to ~80% at 9 hpi. 
Thus, our results show that RIG-I is directly induced at the early stages of viral infection in the 
absence of IFN-.   
We performed two control experiments to validate the observed IFN-independent expression of 
RIG-I. First, we tested Vero cells as this cell line is unable to produce any type of IFN due to 
genetic defects
30
. However, Vero cells do have IFNAR and an intact JAK-STAT pathway, and 
therefore produce ISGs in response to IFN- stimulation. We found that uninfected Vero cells 
have trace amounts of RIG-I transcripts. Cells that are treated with IFN- were found to 
overexpress RIG-I mRNA up to an average of ~120 transcripts per cell. Upon infection with 
SeV, we did not detect any IFN- mRNA at any time point, while the number of RIG-I 
transcripts gradually increased up to ~50 transcripts per cell. We also found that the level of 
MxA, another ISG, was negligible during the course of infection although externally added IFN-
 did up-regulate MxA up to ~240 transcripts per cell, twice as many as that for RIG-I (Fig. 4a, 
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b). Since MxA strictly needs IFN activity for induction after SeV infection, we used it as a 
marker for IFN-dependent pathway in our experiments.  
In the second control experiment, we used quantative RT-PCR (qRT-PCR) to measure the level 
of RIG-I mRNA in HepG2 cells infected with SeV, in the presence of neutralizing antibodies 
against IFN-, IFN-, IFN-, and IFNAR in the culture medium. As a positive control, we 
treated cells with external IFN- for 2 hours and detected 8- and 31-fold up-regulation for RIG-I 
and MxA mRNA respectively (Fig. 4c). The addition of neutralizing antibodies for IFNs and 
IFNAR during IFN- treatment suppressed RIG-I and MxA induction.  At 9 hours post SeV 
infection, we measured 19- and 15-fold induction for RIG-I and MxA respectively. Addition of 
neutralizing antibodies during infection effectively decreased MxA expression, leaving RIG-I 
unaffected (Fig. 4c).  After IFN- treatment, we got approximately 4 times higher fold change in 
MxA as compared to the fold change in RIG-I mRNA level (31- vs. 8-fold). Therefore, the 
15-fold change in MxA mRNA level observed after viral infection correlates to an about 4-fold 
change in RIG-I mRNA level. In this case, the observed 19-fold rise in RIG-I level must be 
mainly due to the IFN-independent pathway. These results together confirm that RIG-I is mainly 
regulated by an IFN-independent pathway at the early stages of viral infection. 
IFN-independent early gene expression is dependent on IRF7 and IRF3 
Further examination of expression kinetics of a small subset of ISGs using smFISH showed the 
differential regulation of ISGs in response to viral infection. Antiviral genes RIG-I, MDA5, 
LGP2, IFIT1, OasL, and Viperin were directly activated by SeV infection as early as 3 hpi, 
displaying bright transcription sites in the nucleus and having cytoplasmic mRNA copy numbers 
higher than that in control cells (Table 1). On the other hand, IRF7, NLRX1, MxA, PKR, and 
TRIM25 did not display elevated levels of mRNA at 6 hpi, while they all are highly expressed 
upon IFN- treatment (Table 1)14, 31-33.  We then used the Nanostring nCounter gene expression 
system to extend our study to a panel of 49 genes, most of which represent the innate immune 
pathway (Table 2).  We calibrated the nCounter with our smFISH data, and calculated that the 
number of transcripts for a gene detected by the nCounter system correlates to sum of transcripts 
of that gene in 10 to 20 cells, detected by smFISH. For example, nCounter detected 306 RIG-I 
transcripts in control cells, which correlates to sum of RIG-I transcripts, detected by smFISH, in 
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11 cells, each of which contain 28 RIG-I transcripts on average (Table 1 and 2). Likewise 
nCounter transcript numbers of TRIM25, LGP2 and MDA5 in control cells correlate to sum of 
transcripts of these genes in 13, 13, and 21 cells respectively (Table 1 and 2).   
nCounter data confirms that major IFN- expression happens at 9 hpi. Number of transcripts 
detected at 6 hpi is likely to be originating from less than 1% of the cells, since the average 
number of IFN- transcripts in an individual cell is ~400, while the nCounter transcript number, 
50, represents 10-20 cells (Table 1, Fig. 4b). At 6 hours post SeV infection, we identified 9 out 
of the 49 genes that were up-regulated and termed them as “early genes”: DDx60, ISG15, IFI6, 
IFIT1, LGP2, MDA5, OasL, RIG-I, and Viperin (Table 1). Several other genes that strongly 
responded to IFN-, such as IFITM3, MxA, Myd88, Oas1, PKR, and TRIM25 were not induced 
at 6 hpi, and are thus termed “late genes” (Table 1 and 2). Up-regulation of most of the early 
genes was also detected at 3 hpi. The expression level of RIG-I does not seem to increase 
compared to control cells at 3 hpi because it initially drops at 2 hpi to about 2/3 of its basal level. 
We confirmed with smFISH experiments that upon infection, single cells that have not activated 
RIG-I, express less RIG-I mRNA at 2, 3, and 6 hpi, compared to before infection (Fig. 5).   
smFISH analysis of single cells revealed that expression of the early genes are highly correlated 
with each other at any given time point after SeV infection. Pairwise analyses of activation of 
RIG-I and OasL, RIG-I and IFIT1, RIG-I and MDA5, and MDA5 and LGP2 show that if a cell 
activates one of these genes, the other paired gene will be activated as well, with almost no 
exceptional cell (Fig. 6, 7a, b).  We calculated high correlation coefficients for early genes in 
individual cells, for instance 0.8 for RIG-I and IFIT1, and 0.68 for LGP2 and MDA5 (Fig. 7b). 
The only exceptional early gene that we observed that did not correlate with others upon viral 
infection is Viperin. While every cell containing Viperin also contained RIG-I, we detected a 
sub-population of RIG-I expressing cells that is not expressing Viperin (Fig. 6, 7a, b). By 
counting transcripts in single cells, we found that RIG-I and Viperin were largely uncorrelated, 
with a correlation coefficient of 0.31 (Fig. 7b).  
Viperin was identified as an IFN-independent gene expressed through an antiviral signaling 
pathway involving peroxisomal MAVS, IRF1 and IRF3
15
. The fact that Viperin and RIG-I 
displayed uncorrelated behavior after viral infection, indicates different pathways responsible for 
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early induction of these genes.  We targeted IRF7 and IRF3 with siRNA to identify transcription 
factors that are required for the early gene expression
34
. Following knockdown, we infected 
HeLa cells for 6 hours with SeV, and performed smFISH to measure RIG-I and IFN- mRNA 
level.  With control siRNA knockdown, cells up-regulated RIG-I and IFN- upon SeV 
infection.  Expression of IFN- was abolished when IRF7 or IRF3 were silenced. In comparison 
to control knockdown, we observed a reduction in the percentage of cells overexpressing RIG-I, 
as well as number of RIG-I transcripts in these overexpressing cells, upon silencing IRF7 or 
IRF3 (Fig. 7b, c). We found that knockdown of IRF7 had a more profound effect in RIG-I 
expression than IRF3. This may explain the uncorrelated expression of RIG-I and Viperin 
following SeV infection, as different mechanisms involving different sets of transcription factors 
may be responsible for their activation.  
Viral load is not a determinant of IFN- activation  
Detection of IFN- transcripts in single cells revealed the heterogeneous nature of IFN- 
expression among the cell population, which would otherwise be obscured in ensemble 
measurements
16, 19-21
 . At any given time from 9 hpi onwards, we observed only a small 
percentage, less than 25%, of the cells expressing IFN-, while more than 70% overexpressing 
RIG-I (Fig. 3a, b).  
Several factors may shape the decision making process of IFN- induction, one of which is the 
variation in the amount of viral replication
24, 25
. We therefore targeted SeV L gene by smFISH to 
quantify viral replication in single cells. SeV infected cells displayed viral mRNA while control 
cells did not show any signal above the background when hybridized with the L gene probes 
(Fig. 8a). At 9 hpi, we counted transcripts of L gene and IFN- in individual HepG2 cells, to find 
out if L gene levels are correlated with IFN- activation. We observed a high degree of variation 
in the viral mRNA expression of the L gene among the IFN- “on” cells with number of 
transcripts going from a few copies to several hundred in single cells. Similarly, IFN- “off” 
cells displayed heterogeneous viral replication states (Fig. 8b, Fig. 9). By counting transcripts in 
single cells, we calculated the Pearson’s correlation coefficient 0.26 for L gene and IFN- (Fig. 
8b). We therefore concluded that the amount of viral load is not a significant determinant of 
bimodal IFN- expression in individual cells.  
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IRF7/3 dependent early genes contribute to decision making process in activation of IFN- 
On the other hand, we found that cells expressing higher amounts of RIG-I are more likely to be 
expressing IFN- (Fig. 8b, Fig. 9). In the same set of cells analyzed for L gene and IFN-, we 
found that RIG-I and IFN- levels are highly correlated. Furthermore, our data revealed a 
threshold to early RIG-I expression for IFN- activation such that all the IFN- expressing cells 
contained more than ~200 RIG-I transcripts (Fig. 8b).  Likewise other early genes, such as 
MDA5, LGP2, and IFIT1 were highly correlated with IFN-, and their expression displayed a 
threshold at their respective transcript levels, at ~200, 60, and 300 (Fig. 8b, Fig.10). Viperin, on 
the other hand, is not correlated with IFN- expression just as it is not with RIG-I and other early 
genes. We found a significant number of cells expressing IFN- with trace amounts of Viperin 
mRNA level (Fig. 8b, Fig.10). Further singe cell analysis show that ISGs that require IFN 
activity for induction, such as TRIM25 and NLRX1, did not correlate with IFN- activation (Fig 
8b)
35
. 
Therefore, we hypothesized that cells need to establish an antiviral gene expression level above a 
threshold value at the early stages of viral infection in order to activate IFN-. In order to test 
this hypothesis, we overexpressed RIG-I prior to viral infection by transfecting a plasmid, and 
monitored IFN-expression following SeV infection. Transfection of RIG-I plasmid alone, 
without viral infection did not activate IFN production. With mock transfection, IFN- 
transcripts were detectable earliest at 6 hpi, in 20% of the HeLa cells. The percentage of the IFN-
 “on” cells significantly went up to 60% at 6 hpi when the cells were transfected with RIG-I 
expression plasmid prior to infection.  Additionally, we were able to detect IFN- earlier at 3 hpi 
in these cells (Fig. 11a, b).  Likewise, transfection of MDA5 expression plasmid also led to an 
increase in the fraction of IFN- producing cells, as compared to mock transfection (Fig. 11c). 
Together, these experiments suggest that IFN-independent expression of early genes may have a 
causal role in activating type I IFN in response to viral infection. 
IRF7/3 dependent early genes may facilitate translocation of NF-B to nucleus  
IRF7/3 and NF-B are the key transcription factors required for activation of the IFN- gene36. 
Our early antiviral gene expression data implied that activation of IRF7/3 happens as early as 3 
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hpi (Fig. 2, Fig. 3b).  Additionally, a high percentage of cells expressed IRF7/3-dependent early 
genes by 9 hpi, indicating that activation of IRF7/3 is fast and robust. However, onset of IFN- 
expression is slower compared to IRF7/3 activation, and happens only in a fraction of the cells, 
which may result from slower kinetics of NF-B activation. These results provoked examination 
of kinetics of NF-B dependent genes, with respect to IRF7/3 -dependent genes, to investigate if 
nuclear translocation of NF-B is more limiting in IFN- expression.  Furthermore, IFN- “on” 
cells contained higher levels of IRF7/3 -dependent genes in contrast to IFN- “off” cells, 
suggesting that IRF7/3 -dependent genes may facilitate NF-B activation.  
To test this, we immunofluorescently labeled NF-B and IRF3, and analyzed the time-course of 
nuclear translocation of both transcription factors upon SeV infection. We observed nuclear 
localization of IRF3 in 6% and 25% of the cells at 3 and 6 hpi respectively, while the fraction of 
cells with nuclear localized NF-B remained at 2% and 6% respectively at these time points.  At 
9 hpi, 64% of the cells displayed nuclear localized IRF3 and 32% of the cells NF-B.  The 
majority of the cells containing nuclear NF-B also contained IRF3, with a few exceptions of 
less than 3% of all the cells imaged at 9 hpi (Fig. 12a, b). These results show that activation of 
NF-B upon viral infection is slower and less efficient compared to IRF3.   
Then, we jointly imaged IFN- (dependent on IRF7/3  and NF-B), TNF- (dependent on NF-
B), and IFIT1 (dependent on IRF7/3) mRNA to quantify kinetics of IRF7/3 and NF-B 
dependent gene expression in single cells. Kinetics of IFIT1 following viral infection was similar 
to that of RIG-I mRNA expression and IRF3 translocation, as expected. TNF- expression, on 
the other hand, was similar to IFN-, both in terms of the fraction of cells activating it (32%), 
and the onset of expression (9 hpi), which is consistent with the kinetics and efficiency of NF-B 
nuclear translocation (Fig. 13a, Fig. 12a, b). IFN “on” cells contained a wide range of TNF- 
transcripts, from a few to hundreds, indicating that TNF- expression level does not place a 
threshold for IFN- activation (Fig. 13b). This is consistent with the fact that TNF- and IFN- 
expression kinetics are similar, and they are delayed compared to IFIT1. Interestingly, IFIT1 
level displayed a threshold for the expression of both TNF- and IFN-, suggesting that higher 
levels of IRF7/3 -dependent genes may facilitate recruitment of NF-B to the nucleus, and thus 
activation of IFN- (Fig. 13b).  
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Discussion 
Although activation of ISGs through signaling triggered by type I IFN binding to the receptor is 
a major innate immune response, a more comprehensive picture is developing with the more 
recent research that reveals other mechanisms through which antiviral gene expression takes 
place
15, 37
. For instance, Dixit et al. have identified peroxisomes as a platform promoting rapid 
and IFN-independent expression of some ISGs, such as Viperin.  In this study, using smFISH, 
we could identify small fraction of cells overexpressing RIG-I and several other genes upon viral 
infection, IFN-independently, whereas if we relied on bulk measurements, such as qPCR, some 
of this information would be lost due to the ensemble averaging over the entire population. 
Furthermore, only when we analyzed the expression of these genes at the single cell level, could 
we see that there may exist different mechanisms responsible for IFN-independent gene 
expression upon viral infection. 
smFISH is a convenient method for the detection of cytokines in single cells as it is hard to 
detect the protein because it is secreted. We exploited the multicolor nature of this technology to 
study the well-known heterogeneity in the IFN- expression in single cells38. Our results together 
suggest that one limitation in the activation of IFN- gene may be the expression levels of 
IRF7/3 dependent early genes and their effect on subsequent activation of the NF-B 
transcription factor.  IRF7/3 -dependent gene expression is detected in every IFN- and TNF- 
“on” cells above a threshold, suggesting that higher levels of IRF7/3 dependent genes may foster 
recruitment of NF-B to the nucleus.  Further study is required to understand the stages at which 
the early genes may help recruit NF-B. One recent publication shows that RIG-I regulates NF-
B activity through binding to NF-B 3’-UTR mRNA, showing evidence for how RIG-I may 
help NF-B recruitment39.  We still observe a fraction of IFN- “off” cells although containing 
high levels of early genes. Therefore, other than the expression level of IRF7/3 dependent genes, 
there must be additional limitations to the activation of IFN-, upstream of nuclear translocation 
of NF-B.  There is also a fraction of TNF- expressing, and thus nuclear NF-B containing 
cells which do not express IFN-. This implies additional limitations to the activation of IFN-, 
downstream of NF-B nuclear translocation, such as promoter binding and interchromosomal 
associations
15
. 
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Viral pathogenesis is a complex process. The outcomes of viral infection—whether to effectively 
suppress the viral replication, produce more progeny viruses, die or live in the process—are 
initially determined by interplay of a number of viral and host factors at the cellular level. Our 
results show that there is a high degree of heterogeneity in the viral replication and host gene 
expression in individual cells. smFISH can be exploited to study virus-host interactions at single 
cell level to identify the viral and host factors that underlie the decision making process during 
infection that lead to heterogeneous cell fates.  
Experimental Procedures 
Single molecule fluorescence in situ hybridization 
Design of probes 
The set of FISH probes consist of 35 to 48 different 20mer DNA oligonucleotides, each 
complementary to a different region of the target RNA. We try to design oligonucleotides with 
similar GC content to ensure binding of as many probes as possible at a given hybridization 
condition. In order to design such probe sets, we use publicly accessible computer program 
(available at www.singlemoleculefish.com), that generates list of probe sequences for the target 
mRNA sequence with GC contents as uniform as possible; typically optimized to about 45% for 
each probe. 
We order the designed oligonucleotides synthesized with an amino group at their 3’ ends for the 
subsequent coupling of fluorophores, from Biosearch Technologies (Novato, CA, USA). 
Oligonucleotides arrive in a 96-well plate format at a scale of 10nmol per oligonucleotide, 
desalted and re-suspended in water at 100 uM concentration.  
Coupling of probes with fluorophores 
We use fluorophores Cy3 NHS ester (GE Amersham), Alexa Fluore 594 succinimidyl ester 
(Invitrogen), and Cy5 NHS ester (GE Amersham) to couple to the 3’ amine groups of the 
oligonucleotides. Using appropriate filter sets (Table 3), these fluorophores can be used to image 
three different mRNA species without leakage between the channels. 
 Pool 5 ul (0.5 nmol) of all oligonucleotides together.  
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 Add 0.1 volume of 1M sodium bicarbonate (pH 8) to the oligonucleotide solution. 
 Dissolve 0.2 mg dye in 5 ul DMSO, and then add this into the oligonucleotide solution. 
 Mix and incubate overnight in the dark, at room temperature. 
In order to remove the uncoupled dye from the oligonucleotides, we perform ethanol (EtOH) 
precipitation: 
 Add 0.1 volume of 3M sodium chloride (NaCl) 
 Add 2.5 volume of EtOH 
 Store at -20C for at least 1 hour. 
 Spin in a -4C microcentrifuge at maximum speed for 20 minutes.  
 Remove supernatant. Resuspend the pellet (contains the coupled and uncoupled 
oligonucleotides) in 0.1 M triethylamine acetate (TEAA) pH 8 buffer. 
Purification of coupled probes 
We purify the coupled oligonucleotides from the uncoupled by HPLC. As the fluorophores we 
use are hydrophobic, they increase the hydrophobicity of the oligonucleotides upon coupling. 
Therefore the coupled oligonucleotides are retained on a reverse-phase column longer than the 
uncoupled oligonucleotides. For the purification procedure we use an HLPC equipped with a 
C18 column and a diode array detector. For gradient we use 0.1M TEAA pH 8 (Buffer A) and 
Acetonitrile (Buffer B). 
 Load the oligonucleotide solution onto the column equilibrated with 10% Buffer B. 
 Initiate a program that would linearly raise the proportion of Buffer B to 50% over 32 
minutes. 
 Monitor the absorption of the DNA at 260 nm and the fluorophore at its absorption 
maximum. 
DNA will elute in two major peaks, separated by several minutes depending on the fluorophore 
used. The first peak corresponds to uncoupled oligonucleotides, which is detected only at 260 
nm. The second peak represents coupled probes and is detected in both channels (Fig. 14).  
 Collect the labeled fraction of the oligonucleotides and ethanol (EtOH) precipitate.  
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 Dissolve the pellet in water to a final concentration of ~1 uM oligonucleotides. This is the 
stock solution. 
 For working dilution, make a 1:50 dilution (20 nM) of the oligonucleotides.  
Sample preparation for FISH 
Fixation and permeabilization of cells 
 Grow cells in Lab-Tek chambered coverglass 
 Remove growth medium. 
 Wash with phosphate buffered saline (PBS). 
 To fix the cells, add 4% Paraformaldehyde and incubate at room temperature for 10 minutes. 
 Wash 3X with PBS. 
 Add 70% EtOH and store at 4 °C at least overnight, to permeabilize and store the cells until 
use. 
Hybridization 
 Prepare hybridization solution by adding 1 l of the probes from working dilution into 100 l 
of hybridization buffer. 
 Remove 70% EtOH from the chambers. Add 1 ml wash buffer. Incubate for 5 minutes at 
room temperature. 
 Remove wash buffer, and add hybridization solution into the chambers. Place a clean 
coverslip over the sample to uniformly distribute hybridization solution and to prevent drying 
of the sample. 
 Incubate the sample overnight at 37 °C, in dark.  
 Add 1 ml wash buffer into the chambers and remove the coverslip. Incubate at 37 °C for 30 
minutes.  
 Remove wash buffer. Add another 1 ml of wash buffer. Incubate at 37 °C for another 30 
minutes.  
 Remove wash buffer. Add 1 ml 2X saline-sodium citrate (SSC) and store in 4 °C until use.  
 Remove 2X SSC. Add 1 ml imaging buffer just before imaging. 
Hybridization buffer: 
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 Dextran sulfate (1 g) 
 Escherichia coli tRNA (10 mg) 
 Vanadyl ribonucleoside complex (100 l of 200 mM stock) 
 BSA (RNase free) (40 l of 5 mg/mL stock) 
 20X SSC (1 mL) 
 Formamide (1 mL) 
 RNase free water (to 10 mL final volume) 
Dissolve Dextran sulfate in water. Add the other components. Prepare 0.5 ml aliquots and store 
at 20C.  
Wash Buffer 
 RNase free water (40 mL) 
 Formamide (5 mL) 
 20X SSC (5 mL) 
“Gloxy” 
 Glucose oxidase (10 mg) 
 Catalase ( 20 l) 
 50 mM NaCl, 10 mM Tris-HCl, pH 8 (80 l) 
Dissolve glucose oxidase in Tris buffer. Add catalase. Spin in a microcentrifuge at maximum 
speed for 2 minutes. Take supernatant.  
Imaging buffer: 
 RNase free water (850 l) 
 20X SSC (100 l) 
 10% (w/v) glucose in RNase free water (40 l) 
 2 M Tris–HCl, pH 8.0 (5 l) 
 “Gloxy” (10 l) 
“Gloxy” is added right before imaging. 
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Imaging 
For imaging single mRNAs we use a conventional widefield fluorescence microscope, Zeiss 
Axiovert 200M equipped with Apotome Structured Illumination Optical Sectioning System. The 
microscope is also equipped with: 
 Photometrics Cascade 512b EMCCD camera 
 100X oil immersion objective NA 1.46 
 XCite 120 excitation light source 
 Appropriate filter sets (Table 3) 
30 z-stacks are taken automatically with 0.3 m between the z-slices, with an exposure time of 
0.5 seconds. 
Image analysis 
We use a MATLAB program provided by Arjun Raj, to identify the spots corresponding to 
individual mRNA molecules and count them. The program takes input of optical slices as TIFF 
images, and enhances spots by passing them through a Laplacian of Gaussian filter. Then, it 
applies an intensity threshold to identify spots. To select the appropriate threshold, the program 
counts number of spots detected for all possible threshold values. When we graph number of 
spots identified as a function of threshold value, a plateau region is observed, where the spot 
count does not vary significantly over a broad range of thresholds. This is generally the correct 
threshold to choose, as the spots found at these thresholds matches to those identified by eye. 
The threshold is then manually picked based on the graph and visual feedback (Fig. 14a, b).  
Immunofluorescence protocol 
 Remove the medium and wash the cells with PBS 1X 
 Fix the cells with 3% Paraformaldehyde for 10 minutes at room temperature 
 Wash cells 3X with PBS 
 Permeabilize the cell membrane with a solution of 0.5 % Triton X-100 for 10 minutes 
 Wash cells 3X with PBS 
 Block the sample with a solution of 3 % bovine serum albumin (BSA) for 1 hour  
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 Wash cells 2X with PBS 
 Dilute primary antibodies in PBS. Apply the solution to the chambers and incubate for 2 
hours 
 Wash the cells 3X with PBS, 5 minutes each 
 Dilute secondary antibodies in PBS. Apply the solution to the chambers and incubate for 2 
hours 
 Wash the cells 3X with PBS, 5 minutes each 
Secondary Antibody Labeling Protocol 
 Dilute secondary antibody to 1 mg/ml in PBS. 
 Prepare 1M of sodium bicarbonate solution in PBS 
 Mix the following for the reaction buffer: 
1. 50 l of 1 mg/ml antibody solution 
2. ~1-2 g Alexa Fluor 647 SE, or Cy3 NHS-ester 
3. 10 l of 1M sodium bicarbonate solution 
4. Add PBS to a final volume of 100l 
 Incubate the reaction solution for 30 minutes at room temperature in dark. 
 Purify Antibody using the Bio-Spin 6 columns, following the instruction manual from the 
manufacturer (http://www.bio-rad.com/webroot/web/pdf/lsr/literature/LIT-507G.pdf ). 
Cell Culture and Virus infections 
HeLa, Vero, and HepG2 cells were grown in DMEM supplemented with 10% fetal bovine serum 
(FBS) and 1% penicillin streptomycin (PENSTREP) at 37°C. SeV is provided by Adolfo Garcia-
Sastre. Cells were seeded 24 hours prior to infection. On the day of infection, medium is 
replaced fresh medium containing the virus at MOI:5.  
Plasmid Transfections 
Expression plasmids for RIG-I (pEF-flagRIG-Ifull) and MDA5 (pEF-flagMDA5full) were 
provided by Takashi Fujita. Cells were transiently transfected with plasmids by using JetPrime
™
 
transfection reagent (Polyplus transfection, France) according to the manufacturer's instructions 
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(http://www.polyplus-transfection.com/wp-content/uploads/2009/08/jetPRIME-short-protocol-
DNA-vE.pdf). 
siRNA and transfections 
siRNAs targeting IRF3 (sc-35710) and IRF7 (sc-38011) were obtained from Santa Cruz 
Biotechnology. siRNAs were transfected using Lipofectamine RNAiMax (Invitrogen) according 
to the manufacturer's protocols. 
(http://tools.invitrogen.com/content/sfs/manuals/Lipofectamine_RNAiMAX_Reag_protocol.pdf) 
RNA extractions and qRT-PCR. 
Total RNA was extracted using the RNeasy mini kit (Qiagen) according to the manufacturer’s 
instructions. RNA quality is determined by Agilent 2100 bioanalyzer, and only RNA with RIN 
above 9 is used for reverse transcription reactions. Total RNA (900 μg) was reverse transcribed 
using the iScript™ cDNA Synthesis Kit (BIO-RAD) according to the manufacturer’s 
instructions (http://www.bio-rad.com/webroot/web/pdf/lsr/literature/4106228C.pdf ). PCR 
analysis was carried out using SYBR-Green (Applied Biosystems) according to the 
manufacturer’s instructions (http://tools.invitrogen.com/content/sfs/manuals/cms_042179.pdf ). 
The primer sequences used for RT-PCR were as follows: RIG-I forward: 
GGTTTAGGGAGGAAGAGGTGC, reverse: AAGTGTGGCAGCCTCCATTG; IFN- forward: 
GACGCCGCATTGACCATCTA, reverse: GTGACTGTACTCCTTGGCCT; IFIT1 forward: 
GGCTGCTGTTTAGCTCCCTT, reverse: CCATTTGTACTCATGGTTGCTGTA;  GAPDH 
forward: GACAGTCAGCCGCATCTTCT, reverse: AAATGAGCCCCAGCCTTCTC. 
 
Antibodies 
Type I IFN activity is blocked by addition of 10 g/ml of anti-IFN- (Abcam, ab20200), 10 
g/ml anti-IFN- (R&D systems, AF814), 10 g/ml anti-IFN- (R&D Systems, MAB15981), 
and 5 g/ml anti-IFNAR chain 2 (PBL InterferonSource, 21385-1) into the culture medium 
during infection. Antibodies for IRF3 and NF-B are obtained from Cell Signaling (11904P) and 
Abcam (ab119826) respectively.  
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ELISA 
Verikine human IFN beta ELISA kit (PBL InterferonSource, 41410-1B) is used to quantify IFN-
 from the culture medium according to the manufacturer’s instructions 
(https://interferonsource.com/sites/interferonsource.com/files/41415 Rev.01_Protocol A_0.pdf ). 
  
25 
 
Figures and Tables 
 
Figure 1. (a) The schematics of multicolor single-molecule fluorescence in situ hybridization 
(smFISH) and simultaneous imaging of RIG-I, MxA, and MDA5 mRNA in individual cells 
treated with IFN-. (b) Comparison of RIG-I and housekeeping gene ALAS mRNA expression 
in control and IFN- treated cells. (c) Kinetics of RIG-I mRNA expression post IFN- treatment. 
Transcripts are counted from 10 to 20 cells at each time point. 
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Figure 2. RIG-I and IFN- mRNA are co-detected in individual cells at various time points post 
SeV infection with a lower magnification objective. RIG-I overexpressing cells with bright RIG-
I transcription sites are labeled with yellow arrows. IFN- overexpressing cells are labeled with 
blue arrows.  
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Figure 3. (a) RIG-I and IFN- mRNA are co-detected in individual cells at 3 and 9 hpi. (b) Bar 
chart showing percentage of cells overexpressing RIG-I and IFN- mRNA as a function of time 
post SeV infection. 600 to 1000 cells were analyzed at each time point. (c) ELISA to detect IFN-
 from culture medium at different time points after SeV infection. (d) Average number of RIG-I 
and IFN- transcripts in single cells those have active transcription sites of RIG-I at 3 and 6 hpi. 
Transcripts from 10 to 20 cells are counted at each time point. 
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Figure 4. (a) Transcript levels of RIG-I and MxA in control, IFN- treated (12 hrs) or SeV 
infected (18 hpi) Vero cells. Cell borders are denoted by dashed outlines. (b) Average number of 
RIG-I and MxA mRNA is counted in control, IFN- treated (12 hrs) or SeV infected (6 and 18 
hpi) Vero cells. 10 to 20 cells are analyzed at each condition. (c) qRT-PCR analysis of RIG-I and 
MxA mRNA in control, IFN- treated (2 hrs) in the presence or absence of neutralizing 
antibodies (against IFN-, IFN-, IFN-, and IFNAR) or SeV infected (9 hpi) HepG2 cells in 
the presence or absence of neutralizing antibodies. Fold change calculated relative to that of 
GAPDH. 
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Figure 5. Average number of RIG-I transcripts in single cells, that are not overexpressing RIG-I, 
at 0, 2, 3 and 6 hpi. Transcripts from 10 to 20 cells are counted at each time point.  
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Figure 6. (a) Pairwise imaging of activation of early genes OasL and RIG-I, RIG-I and MDA5, 
MDA5 and LGP2, RIG-I and IFIT1, and RIG-I and Viperin transcripts in HepG2 cells, at 6hpi. 
Each row represents a different imaging area. 
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Figure 7. (a) Chart demonstrating percentage of cells co-expressing RIG-I and OasL at 3 hpi, 
and RIG-I and IFIT1, and RIG-I and Viperin at 9 hpi. 224, 320 and 252 HepG2 cells are 
analyzed for each case respectively. (b) Scatter plots of number of RIG-I vs. IFIT1, MDA5 vs. 
LGP2, and RIG-I vs. Viperin transcripts in single HepG2 cells. (c) Bar chart showing percentage 
of cells overexpressing RIG-I and IFN- mRNA at 6 hour post SeV infection following siRNA 
knockdown of the indicated genes in HeLa cells. (d) Average number of RIG-I transcripts in 
single cells those have active transcription sites of RIG-I at 6 hour post SeV infection, following 
siRNA knockdown of the indicated genes in HeLa cells. Transcripts from 25 to 30 cells are 
counted at each time point. 
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Figure 8. (a) Imaging SeV L gene transcripts in control and infected HepG2 cells. Cell borders 
denoted by dashed outlines. (b) Scatter plots of number of L gene, RIG-I, IFIT1, LGP2, MDA5, 
TRIM25, NLRX1 and Viperin against IFN- transcripts in single HepG2 cells at 9 hpi.  
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Figure 9. Simultaneous imaging of RIG-I, L gene, and IFN- mRNA, at 9 hpi. Each row 
represents a different imaging area. 
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Figure 10. Simultaneous imaging of Viperin, IFIT1 and IFN- mRNA, at 9 hpi. Each row 
represents a different imaging area. 
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Figure 11. (a) IFN- mRNA in HeLa cells at 6 hpi with or without prior RIG-I or MDA5 
transfection. (b) Percentage of HeLa cells expressing the IFN- gene at different time points post 
SeV infection, with or without prior transfection of RIG-I plasmid. (c) Percentage of HeLa cells 
expressing the IFN- gene at 6 hpi, with or without prior transfection of RIG-I or MDA5 
plasmid. 
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Figure 12. (a) Confocal imaging of immunofluorescently labeled IRF3 and NF-B at various 
time points post SeV infection. Scale bar: 50um (b) Percentage of cells displaying nuclear IRF3 
or NF-B as a function of time post SeV infection. 450 to 600 cells were analyzed at each time 
point. 
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Figure 13. (a) Percentage of cells overexpressing IFIT1, TNF-, or IFN- mRNA as a function 
of time post SeV infection determined by smFISH. 250 to 450 cells were analyzed at each time 
point. (b) Scatter plots of number of IFIT1 vs. TNF-, and TNF- vs. IFN- transcripts in single 
HepG2 cells. 
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Figure 14. Sample HPLC chromatograph showing absorbance at 260 nm (oligonucleotides) and 
650 nm (Cy5). The first 260 nm peak that elutes at 22 seconds is the uncoupled oligonucleotides. 
The second peak that elutes at 34 seconds has absorption at both the 260 and 650 nm, indicating 
that this is the fluorophore coupled oligonucleotides. 
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Figure 15. (a) An individual cell (border indicated by red line) displaying single spots 
corresponding to individual mRNAs. (b) Individual spots identified by the software shown with 
green circles, at the chosen intensity threshold value that is indicated by green line in (c) (c) 
graph of number of spots identified as a function of threshold value, displaying a plateau region 
where the spot count does not vary significantly. 
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Table 1. The mean number, with standard deviation, of transcripts detected per cell in control, 
IFN- treated and SeV infected cells, by smFISH. 
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Table 2. Number of transcripts detected by Nanostring nCounter gene expression system in 
control, IFN- treated (2h), and SeV infected (2, 3, 6, and 9 hpi) HepG2 cells. Fold change with 
respect to control sample is indicated in parenthesis.  Number of transcripts is normalized to 
housekeeping genes GAPDH and ALAS.  
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Table 3. The fluorophores and filter sets used in the smFISH experiments 
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Chapter 3 
Application of Super-Resolution 
Microscopy Towards Antiviral Signaling
†
 
Introduction 
Fluorescence microscopy is an essential tool in biology. The noninvasive nature of light allows 
researchers to image biological processes in living cells with little perturbation. An array of 
fluorescent probes and labeling techniques, such as immunofluorescence, fluorescence in situ 
hybridization, and genetically encoded fluorescent tags makes it possible to image specific 
biological targets with a high degree of specificity. Furthermore, fluorescence microscopy 
enables simultaneous imaging of multiple species by multicolor labeling with spectrally distinct 
fluorescent probes
1
. 
Despite the advantages, fluorescence microscopy has long been limited by diffraction to a spatial 
resolution of >200 in lateral dimensions, and >500 nm in axial dimension, leaving many 
biological structures too small to study in detail
2
. With the recent developments in super-
resolution imaging techniques, however, the resolution limit of conventional fluorescence 
microscopy has been surpassed. One such technique relies on imaging single photoswitchable 
fluorophores, whose fluorescent state can be switched from a dark state to a bright state. This 
technique was developed by three different research teams, and was referred to as stochastic 
optical reconstruction microscopy (STORM), photoactivation localization microscopy (PALM) 
and fluorescence photoactivation localization microscopy (FPALM)
3,
 
4,
 
5
. 
In this chapter we describe the methodology of STORM, such as photoswitchable fluorescent 
probes, STORM microscope design, data collection and analysis procedure, preparing samples, 
as well as its applications to various cellular structures and antiviral signaling.  
                                                          
†
 This work was done in collaboration with Seongjin Park, Digvijay Singh and Jingyi Fei, from Taekjip Ha lab, 
University of Illinois at Urbana-Champaign 
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The diffraction limit 
Spatial resolution of the optical microscopes is limited by diffraction of the light, as shown by 
Ernst Abbe in 1873
6.  Ernst Abbe found that light with wavelength λ, traveling in a medium with 
refractive index n and converging to a spot with angle  will make a spot with diameter 
 
The Abbe limit is roughly 250 nm, for green light around 500 nm, which is large compared to 
most biological structures which have sizes on the order of nanometers to microns.  
Localizing single molecules with high precision 
Although its image appears as diffraction limited, broad peak of several hundred nanometers in 
width, the position of an isolated fluorescence emitter can be precisely localized by determining 
the center of its emission pattern. It has been shown that a two-dimensional Gaussian function is 
the best fit to images of a single fluorescent dye, referred as a point spread function (PSF). The 
standard error of the mean (SEM) of the PSF is a measure of localization and it can be made 
small by collecting more photons and minimizing the noise factors
7, 8
. The precision of this 
localization process is given by: 
 
where s is the standard deviation of the Gaussian distribution, a is the pixel size, b is background 
and N is number of collected photons. It has been shown that the position of a single dye 
molecule can be determined with a precision as high as ~1nm
9
. 
Localizing isolated single emitters with high precision, however, does not directly translate into 
image resolution. The emission patters of multiple fluorophores will overlap with each other, if 
47 
 
they are separated from each other by a distance less than the PSF width, and this prevents 
accurate localization of the fluorophores. 
Stochastic optical reconstruction microscopy (STORM) 
In order to be able to localize multiple fluorescent emitters that are in close proximity, one could 
exploit use of photoswitchable fluorophores: molecules that can be switched between a dark and 
a bright fluorescent state, which can be controlled by light. The fluorescent states of these probes 
can be controlled in a way that ensures at any point in time, only a sparse subset of the 
fluorophores in the sample is in the bright state. As long as the images of the single molecules 
are not overlapping, each molecule can be localized with high precision. The molecules, whose 
positions have been determined, now can be switched off to the dark state, allowing activation of 
a new subset of molecules that can be imaged and localized. By repeating this cycle of 
activation, localization, and deactivation, the positions of numerous closely spaced fluorophores 
may be determined. 
STORM was established as an imaging method based on this principle, which is illustrated in 
Figure 16. The STORM imaging process consists of many cycles of activation, imaging and 
deactivation of fluorophores. The density of the activated molecules depends on the intensity of 
the activation light. Shining a weak activation light ensures a low density of fluorophores in the 
bright state, thereby allows positioning of single molecules with high precision. After many 
cycles of imaging, one can determine positions of sufficient number of molecules, which can be 
used to reconstruct the super-resolution image
5
. 
Photoswitchable Fluorescent Probes 
A fluorescent molecule is called photoswitchable when its spectral characteristics can be 
switched between different states under the control of an external light source.  Several 
fluorescent proteins and organic fluorophores have been shown to display photoswitching 
behavior. YFP (yellow fluorescent protein), for instance, was shown to cycle reversibly between 
a fluorescent and a dark state by alternating exposure to blue and violet light
10
. Similar effects 
were observed with organic fluorophores, such as the red cyanine dye Cy5, which can be 
reversibly converted between a fluorescent state and a dark state
11, 12
. Photoswitchable 
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fluorophores have found increasing application for super-resolution imaging. A wide variety of 
photoswitchable synthetic fluorophores and fluorescent proteins are now available in a range of 
colors
13, 14
.  
We use Alexa Fluor 647 and Alexa Fluor 568 in our STORM experiments. The photoswitching 
behavior of these dyes is dependent on the presence of a thiol-containing molecule in the 
imaging solution such as -mercaptoethanol (ME) or -mercaptoethylamine (MEA)13. When 
red and yellow lights are shined onto Alexa Fluor 647 and Alexa Fluor 568 dyes respectively, 
they are initially fluorescent before switching into a dark state. When they are then exposed to 
UV light, a significant fraction of the molecules rapidly return to their fluorescent state. The 
reactivation can be made significantly more efficient when these dyes are paired, in close 
proximity, with a second fluorophore that absorbs UV light, such as Alexa Fluor 405
15
. Alexa 
Fluor 647 and Alexa Fluor 568 dyes are termed as reporter dyes, as they are imaged to reveal the 
super-resolution structure. Alexa Fluor 405 is termed activator dye, as it is used to reactivate the 
reporter dyes. We then pair Alexa Fluor 647 with Alexa Fluor 405 to make an optical switch 
which is turned off with red laser (647 nm) and turned on with violet laser (405 nm). When we 
do two-color imaging, we pair Alexa Fluor 568 with Alexa Fluor 405 to make another spectrally 
distinct optical switch, which is turned off with yellow laser (647 nm) and turned on with violet 
laser (405 nm). 
Instrumentation 
The STORM instrumentation is described in Figure 17. We use Olympus IX-71, a standard 
inverted fluorescence microscope frame.  The microscope is equipped with a 100X NA 1.4 oil 
immersion objective that allows for both epi-fluorescence and objective-type total internal 
reflection fluorescence (TIRF) illumination schemes.  
The imaging and the activation lasers are combined into a single beam using dichroic mirrors, 
which is then expanded by 7.5 times, and collimated using a pair of achromatic lenses. The 
collimated beam is focused on the back focal plane of the objective by using an achromatic lens. 
This lens is mounted on a translation stage, which allows adjustment of the incidence angle of 
the illumination light. For imaging cells, we set the incidence angle to near the critical angle of 
the glass-water interface. This scheme allows illumination of several micrometer of thickness 
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into the sample. For imaging thin samples, incidence angle can be adjusted for a narrower depth 
of illumination and lower background
16, 17
. 
We use two lasers at 647 and 568 nm to image Alexa Fluor 647 and Alexa Fluor 568 
respectively. Both lasers have a power output of 100 mW. We use an additional laser at 405 nm 
for activation of the photoswitchable fluorophore pairs that use Alexa Fluor 405 as an activator 
fluorophore. Laser intensities are controlled by passing the laser through a half-wave plate 
followed by a polarizing beam-splitter cube. Rotating the wave plate rotates the polarization, 
which, in turn, modulates the amount of light passing through the beam splitter. Neutral density 
filters are also used to further control laser intensities. Electronically controlled laser shutters are 
used to switch the illumination between the imaging and the activation lasers, in synchrony with 
the data acquisition.  
The emission light is passed through bandpass filters designed to collect fluorescence from either 
Alexa fluor 647 or Alexa Fluor 568, and notch filters designed to block 647 and 568 nm laser 
lines. Signal is detected on an EMCCD camera suitable for low-light fluorescence imaging, as 
STORM relies on detection of single fluorescent molecules. We place two achromatic lenses into 
the emission path to magnify the image for an additional 1.5 times. For 3D STORM imaging, we 
place a cylindrical lens into the emission path to induce astigmatism
18
. The image is acquired by 
a home written data acquisition program (C++) and saved on the computer. The program also 
controls laser shutters in synchrony with the camera frames.  
Because the STORM data is collected over a long period of time, we encounter both lateral and 
axial drifts. The lateral drift is corrected for during the data analysis procedure. We use CRIFF 
(Continuous reflective-interface feedback focus system), a commercially available device, that 
substantially eliminates focus drift for high power microscopy. The CRIFF is based on a weak IR 
laser (780 nm), which passes through the objective lens, is reflected off the sample-coverglass 
interface, and is then projected onto a quadrant photodiode (QPD). The position of the beam on 
the diode reports any relative motion between the objective lens and the sample, and this signal 
is fed back to a piezoelectric objective, which corrects for the motion (Fig. 17). 
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Sample Preparation 
We prepare samples for STORM imaging using immunofluorescence. Immunofluorescence 
technique uses the specificity of antibodies to their antigen to target fluorescent dyes to specific 
biomolecule targets within a cell, and therefore allows visualization of the abundance and  
distribution of the target molecule in the sample (Fig. 18)
1
. 
Our immunofluorescence protocol involves aldehyde fixation of the sample to preserve the cell 
morphology by cross-linking proteins. Cells are then treated with a mild detergent to dissolve 
small holes in the membranes, so the antibodies could have access to the cytoplasm. We improve 
staining by blocking the non-specific binding of the antibodies to the specimen. The sample is 
then incubated first with the unlabeled primary antibody that specifically binds the target 
molecule, and then with the dual-labeled secondary antibody that binds to the primary antibody. 
Immunofluorescence Protocol 
 Remove the medium and wash the cells with PBS 1X 
 Fix the cells with 3% Paraformaldehyde for 10 minutes  
 Wash cells 3X with PBS 
 Permeabilize the cell membrane with a solution of 0.5 % Triton X-100 for 15 minutes 
 Wash cells 3X with PBS 
 Treat the sample with Image iT-FX (Invitrogen) signal enhancer for 30 minutes 
 Wash cells 3X with PBS 
 Block the sample with a solution of 3 % BSA for 1 hour  
 Wash cells 3X with PBS 
 Dilute primary antibodies in PBS. Apply the solution to the chambers and incubate for 2 
hours 
 Wash the cells 3X with PBS, 5 minutes each 
 Dilute secondary antibodies in PBS. Apply the solution to the chambers and incubate for 2 
hours 
 Wash the cells 3X with PBS, 5 minutes each 
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Secondary Antibody Dual-Labeling Protocol 
 Dilute the antibody to 1 mg/ml in PBS. 
 Prepare 1M of sodium bicarbonate solution in PBS 
 Mix the following for the reaction buffer: 
1. 50 l of 1 mg/ml antibody solution 
2. ~10 g  Alexa Fluor 405 SE 
3. ~1-2 g Alexa Fluor 647 SE (or Alexa Fluor 568 SE) 
4. 10 l of 1M sodium bicarbonate solution 
5. Add PBS to a final volume of 100 l 
 Incubate the reaction solution for 30 minutes at room temperature in dark 
 Purify Antibody using the Bio-Spin 6 columns, following the instruction manual from the 
manufacturer (http://www.bio-rad.com/webroot/web/pdf/lsr/literature/LIT-507G.pdf ). 
 Take absorption spectrum to determine labeling efficiency (Fig. 18b).  
 
Imaging Buffer 
Prior to imaging, the appropriate imaging buffer is added into the sample well. For the 
photoswitchable Alexa Fluor dyes, we use a buffered solution of pH 8 that contains 50 mM Tris 
and 10 mM NaCl. This buffer contains and oxygen scavenging system consisting of pyranose 
oxidase (~0.1 mg/mL), catalase (~40 μg/mL), and glucose (~10% w/v) to reduce the effects of 
photobleaching. Furthermore, a thiol compound, such as ME or MEA is included in the 
solution to enable photoswitching of the dyes.  
To prepare imaging buffer: 
Mix: 
 5 l of ME  
 1 l of catalase 
 2.5 l of pyranose oxidase solution 
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 Base imaging buffer to a final volume of 500 l 
Base imaging buffer:  
 10 mM sodium chloride (NaCl), 50 mM Tris pH 8.0, 10 % (w/v) glucose  
Pyranose oxidase solution:  
 Dissolve 5 mg pyronase oxidase in 250 l PBS 
Data Collection 
During the STORM experiment, a series of images is recorded, showing individual fluorophores 
switching on and off in time. We record 20-40 thousand image frames, 256 × 256 pixels each, at 
a 30 ms frame rate.  
The procedure for STORM data collection is as follows (Fig. 19): 
 Switch the fluorophores off: We briefly shine imaging laser to the sample to send the 
fluorophores to the dark state. 
 Activate a subset of fluorophores: We expose the sample to a weak activation laser for 30 
milliseconds, which causes some of the fluorophores to switch to the fluorescent state. 
The intensity of the activation laser is adjusted to control the density of fluorophores 
activated. As the experiment proceeds and some fluorophores are permanently 
photobleached, the activation light intensity may be increased to maintain the density of 
activated fluorophores. 
 Image the fluorophores and switch them off: We send the imaging laser to the sample to 
image the activated fluorophores. The density of the activated single fluorophores is low 
enough, such that their images do not overlap. We take 3 sequential images of the 
activated fluorophores. This takes long enough time for these molecules to switch off 
before the next activation frame. The intensity of the imaging laser can be adjusted to 
make sure all fluorophores switch off before the next activation frame.  
 Activate a new subset of fluorophores and image. Activation of a subset of fluorophores 
and imaging them constitute one STORM imaging cycle. We repeat the cycle for 20-40 
thousand times.  
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 Image the second color. We first image Alexa Fluor 647 channel, for which we use red 
laser (647 nm) to image, and violet laser (405 nm) to activate. After imaging the Alexa 
Fluor 647 channel for 20-40 thousand frames, we move onto the Alexa Fluor 568 
channel, for which we use yellow laser (568 nm) to image, and violet laser (405 nm) to 
activate. 
Data Analysis 
The data analysis algorithm is based on Mark Bates’ IDL code which was described in the initial 
STORM papers
5
. We modified the original code to handle multi-color and 3D images.  
The raw data is composed of many cycles of frames. One cycle contains one activation frame 
and three imaging frames. As the activation laser does not excite reporter dyes, the activation 
frames contain no signal. Therefore, activation frames are not taken into account in the data 
analysis.  
Peak Identification and Fitting 
The first task is to identify single molecule images and precisely determine their positions by 
fitting. In order to get rid of noises from various sources such as the EMCCD sensor or ambient 
lights, we take the single molecule images through blurring by Gaussian convolution of 9X9 
pixels.  
Identification Step #1: A single molecule image is several folds brighter than the background. To 
identify single molecules, a user defined intensity threshold (usually ~4) is introduced. In order 
to get the average fluctuation of the signal and noise in individual frames, we calculate the 
standard deviation of the intensity in that frame. Then, we find all the pixels whose values are 
greater than the multiplication of the threshold and the standard deviation of the frame.  
Identification Step #2: Next we find the local maximum intensity pixels whose intensity value is 
greater than its 24 surrounding pixels. The local maximum intensity pixel would represent the 
intensity peak of a single molecule, whose image spans 25 pixels. 
Identification Step #3: Some of the local maximum intensity pixels could come from multiple 
molecules whose images overlap, or bright non-specific signals on the surface. We get rid of 
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them by applying two filters based on sharpness and roundness of the image. Sharpness is 
defined as the intensity ratio between the peak and the background. Bright, non-specific signals 
typically have much higher sharpness value than single molecules, so we can filter them out with 
by applying the sharpness filter. Roundness is defined as the ratio between x variance and y 
variance in 9X9 pixels. Overlapping images of more than one single molecules are usually not as 
round as single molecule images. Therefore applying this filter eliminates images of multiple 
molecules (Fig.20).  
Fitting and Identification Step #4: For images that passed the sharpness and roundness filters, a 
square region of 19X19 pixels surrounding local maximum intensity pixel is fitted with an 
Elliptical Gaussian function. 
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Where   is the background level,   is the amplitude of the peak,    and    are elliptical widths, 
   and   are the center coordinates of the peak
5
. If the software fails to fit any 19X19 square 
region of pixels with a Gaussian function, then that region is discarded.  
During data analysis, the z-positions of the molecules are determined by comparing their    and 
   values to a calibration curve, that we generated from distributions of     and    values of 
images of fluorescently labeled single antibodies, as we moved the objective in z direction (Fig. 
21).  
Trail Generation 
A single fluorophore can blink multiple times, appearing in consecutive frames, which may lead 
to double counting and less precision in the final image. To avoid this, we connect molecules that 
appear in consecutive frames by generating trails. If a trail is longer than 10 frames, it is 
discarded since it may come from non-specific signals which do not photobleach. After trails are 
generated, further filters (roundness, sharpness, maximum ellipticity and photons detected) are 
applied on each peak in every trail, to remove unqualified peaks. Then, for each trail, the final 
localization of the molecule is calculated from the average of center positions of the peaks within 
the trail, weighted by photon numbers in each frame.  
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Drift Correction 
Any kind of drift such as vibration or thermal expansion would blur the final image since each 
image at each frame would shift over time. Z-drift is prevented in real time by a commercial 
feedback system called, CRIFF. The horizontal drift is corrected during data analysis. There are 
two methods we use.  
Drift Correction by fast Fourier transformation: We divide the STORM dataset with equal 
number of frames, and get sub-STORM images that look similar to each other, except for the 
effect of drift. We, then apply fast Fourier transformation (FFT) on each sub-STORM image. By 
comparing the center images in each transformed image, we determine the relative drift among 
sub-STORM images. By linear interpolation, we correct for the drift through all the frames (Fig. 
22). 
Tracking a fiducial marker: Another way to correct for the drift, is to track the position of a 
fiducial marker, such as a nano-diamond, during data acquisition. The change in the position of 
the marker is subtracted from each frame, yielding a drift-corrected image.   
STORM image Rendering 
The final image is generated by plotting each localization as one point. These points can be 
either cross shaped markers or Gaussian rendered peaks. The size of rendered peaks would be 
proportional to the photon numbers of localizations.  
Color options: The localizations in the final STORM image can be plotted in different colors 
based on their z values or their frame numbers. Coloring based on their z values is informative 
about the z-positions of localizations when they are plotted in 2D, while coloring based on frame 
number reveals when each localization was detected.  
Two color visualization: After generating a STORM image, the software creates a storage file 
that includes the coordinates, photon number and the color of each localization. We generate 
separate storage files for each channel. Multiple storage files for different colors is combined 
together to generate multi-color images. 
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Generating a far-filed image: The software generates a conventional diffraction limited far-field 
image to compare to the STORM image, by summing up all the frames of the raw data. Since 
each frame contains stochastic subset of the total fluorescence, summing them all up would give 
a total fluorescence image. The software subtracts a certain background value from each frame 
before summing up, since otherwise the background accumulates and overwhelms the signal. 
Drift correction is also applied during generation of diffraction limited image (Fig. 23, 24).  
Example Applications of Super-Resolution Imaging 
STORM has been used to widely to demonstrate sub-diffraction limit resolution in mammalian 
cells
15,
 
18,
 
19
. In this section we will describe STORM imaging of microtubules, mitochondria and 
clathrin-coated vesicles to demonstrate the resolution capability of STORM. We will next 
describe STORM imaging of RIG-I in the virally infected cells that provided new information as 
compared to a conventional fluorescence imaging.   
Microtubules are found throughout the cytoplasm of all eukaryotic cells and carry out a variety 
of functions, ranging from transport to structural support. To image microtubules with STORM, 
BSC-1 cells (Kidney Epithelial Cells of Monkey Origin) were fixed and immunostained with 
photoswitchable-probe (Alexa Fluor 405 and Alexa Fluor 647) labeled antibodies against -
tubulin. A conventional image of the microtubules is shown in Figure 23. A STORM image of 
the same area shows significantly greater details and makes identification of the individual 
filaments possible. 
Clathrin is a protein that plays a major role in the formation of coated vesicles. To image 
clathrin coated vesicles with STORM, BSC-1 cells were fixed and immunostained with 
photoswitchable-probe (Alexa Fluor 405 and Alexa Fluor 647) labeled antibodies against 
clathrin. A conventional image of the clathrin coated vesicles is shown in Figure 24. A STORM 
image of the same area shows significantly greater details of the spherical hallow structure of the 
vesicles. 
Microtubules and mitochondria: To demonstrate simultaneous imaging of microtubules and 
mitochondria with STORM, BSC-1 cells were fixed and immunostained with Alexa Fluor 405 
and Alexa Fluor 647 labeled antibodies against MAVS (mitochondrial antiviral signaling: a 
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protein localized to mitochondrial outer membrane), and with Alexa Fluor 405 and Alexa Fluor 
568 labeled antibodies against -tubulin (Fig. 25).   
Super-Resolution Imaging of RIG-I in Virally Infected Cells 
Introduction 
Toll-like receptors (TLRs) and retinoic acid-inducible gene-I-like receptors (RLRs) serve as 
pattern recognition receptors (PRRs) that recognize viral components. They are expressed in 
different cellular compartments such as the cell surface, endosome, lysosome or cytoplasm and 
activate specific signaling pathways that lead to expression of antiviral genes. While several 
TLRs, including TLR3, 7, 8, 9 detect extracellular viral RNA and DNA in the endosome, RLRs 
bind to viral RNA of actively replicating virus in the cytoplasm
20, 21
. Although RLRs have not 
been found to be associated with any subcellular structure at steady state,  it has been recently 
shown that infection by Influenza A virus lacking NS1 (IAVNS1) causes RIG-I to form 
cytoplasmic granular aggregates that contain stress granule markers, by using fluorescence 
microscopy
22
.  
Understanding spatial distribution of receptors is essential for elucidating their antiviral role. 
Fluorescence microscopy, however, has long been limited by diffraction to a spatial resolution of 
>200 in lateral dimensions, and >500 nm in axial dimension, leaving many biological structures 
too small to study in detail
2
. With the recent developments in super-resolution imaging 
techniques, however, the resolution limit of conventional fluorescence microscopy has been 
surpassed
5, 3, 4
. Here we report first super-resolution imaging of RIG-I in the infected cells by 
stochastic optical reconstruction microscopy (STORM), which reveals clusters of RIG-I in the 
antiviral stress granules.  
Results 
RIG-I localize to stress granules upon various stress conditions 
To image cellular localization of RIG-I, we transfected MEF cells with poly I:C, a synthetic 
analog of double-stranded RNA (dsRNA). 12 hours after transfection, we fixed the cells and 
labeled RIG-I using immunofluorescence. RIG-I was dispersed in the cytoplasm of the 
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uninfected cells. On the other hand, RIG-I exhibited speckle-like distribution in the cytoplasm in 
cells transfected with poly I:C. These speckles also contained stress granule marker T-cell-
restricted intracellular antigen-related protein (TIAR) (Fig. 26a). We observed that RIG-I 
localizes to stress granules under various stress conditions, such as infection with IAVNS1, 
treatment with sodium arsenite, and exposure to heat (Fig. 26a).  
RIG-I forms clusters in stress granules 
Next, we used super-resolution optical reconstruction microscopy (STORM) to image spatial 
organization of RIG-I within individual stress granules.  We labeled RIG-I via 
immunofluorescence, with secondary antibodies dual-labeled with photoswitchable fluorophore 
Alexa Fluor 647 and Alexa Fluor 405. Only a sparse subset of the Alexa Fluor 647 molecules 
was activated with 405 nm laser at any time, such that the images of individual molecules did not 
overlap. The activated molecules were then imaged with a 647 nm laser. The positions of the 
activated molecules were determined from the centroid positions of Gaussian fits to the 
fluorescence images of the single molecules. Iterating this procedure allowed numerous 
molecules to be localized to construct the super-resolution image.  
In contrast to the conventional images where RIG-I seems dispersed, STORM images reveal 
clustering of RIG-I in the stress granules (Fig. 27). TIAR, on the other hand, does not display as 
much clustering as RIG-I (Fig. 28d, e). In order to quantify clustering, we used the cluster 
analysis algorithm DBSCAN (Density-based spatial clustering of applications with noise). 
DBSCAN employs two parameters, Npts and Eps, to form clusters. First, the clusters are formed 
with points in a distance Eps, and with surrounding points more than Npts. Then, the clusters are 
expanded by including points within Eps distance (to any points in the cluster), that is 
surrounded by points more than Npts
23,
 
24
. This way a cluster can extend to distances more than 
Eps. We chose the parameters Npts=7 and Eps=37 nm that best describes the RIG-I clusters, 
based on visual feedback (Fig. 28c). 
Using these parameters, we identified clusters of RIG-I in the stress granules induced by poly I:C 
transfection, and calculated the percentage of localizations within clusters in the stress granules. 
We found that 55% of the entire RIG-I localizations in the stress granules were within the 
clusters. We observed RIG-I forms clusters in the cytoplasm as well, containing 59% of all the 
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cytoplasmic localizations. In contrast, TIAR was more dispersed, both in the stress granules and 
cytoplasm, and displayed a smaller fraction, 14 and 9%, respectively, of localizations in the 
clusters (Fig. 29a). 
Next we measured the sizes of the clusters. The average size of RIG-I clusters in the stress 
granules was 55 nm, significantly larger (~40%) than cytoplasmic clusters of size 39 nm. We 
found that TIAR clusters both in the cytoplasm and stress granules had smaller cluster size than 
RIG-I in the stress granules (Fig. 29b).  
RIG-I clustering is independent of dsRNA 
To determine if the observed clustering of RIG-I is dependent on dsRNA, we imaged RIG-I 
under various stress conditions, such as infection with IAVNS1, treatment with sodium arsenite 
or heat shock. We observed that RIG-I clusters under all the mentioned stress conditions, 
indicating that the clustering is dsRNA independent (Fig. 30a). Under these stress conditions, the 
percentage of RIG-I localizations contained in the stress granules were similar in all cases (52-58 
%) to clusters induced with poly I:C transfection (Fig. 30b). Furthermore, we obtained similar 
sizes for clusters (43-52 nm) under various stress conditions, consistent with cluster sizes 
obtained with poly I:C transfection (Fig. 30c).  
Experimental Procedures 
Cell Culture, virus infection, transfection 
MEF cells were grown in DMEM supplemented with 10% FBS and 1% PENSTREP at 37°C. 
IAVNS1 is provided by Adolfo Garcia-Sastre. Cells were seeded 24 hours prior to infection or 
transfection. Cells were transiently transfected with 5 g poly I:C by using JetPrime™ 
transfection reagent (Polyplus transfection, France) according to the manufacturer's instructions 
(http://www.polyplus-transfection.com/wp-content/uploads/2009/08/jetPRIME-short-protocol-
DNA-vE.pdf). 
Cell were infected with IAVNS1 in serum-free medium, at MOI:5. After adsorption for 1 hour, 
virus containing medium is changed to serum-containing medium. 0.5 mM sodium arsenite 
(Sigma) was added to the cell culture for 1 hour. Cells were incubated at 44 °C, for 30 minutes.  
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DBSCAN cluster analysis 
The algorithm for segregating points into clusters using DBSCAN is divided into two process, 
the first one called Cluster Initiation and then second one Cluster Expansion. It starts with 
defining two parent arrays. The first one is called VisitArray and the second one is ClassArray. 
The VisitArray keeps tab of whether a point has been analyzed before or not by keeping a visit 
tab i.e. 0 for an unvisited/non analyzed point and 1 for a point that has been analyzed and already 
has been either put under a cluster or termed as noise. 
The scan starts off with any random non-visited point and a check is made if the given point has 
more than Npts number of points in its neighborhood defined by Eps radius and if the check is 
incorrect then the point's VisitArray is updated to visited by shifting the value to 1 and is termed 
a noise point in the ClassArray. At the correct check a cluster is initiated with the cluster number 
1 with the establishment of a neighborhood array which has all these Npts or more than Npts 
found in the check. The cluster number is 1 for the first initiation, these gets incremented 
following each new initiation of the cluster in any unvisited set of points. The scan now moves 
recursively to each of these points in this established neighborhood, a process called as 
expansion of the initiated cluster, and follows the same check procedure to each point and 
recursively adds more and more number of points to the neighborhood as the neighborhood 
points collect more neighborhood points which are in their vicinity. This process is repeated until 
the complete check has been made on all the neighborhood points, while updating their 
VisitArray values. This set of neighborhood points for a given initiated cluster also recursively 
grows till a point when there is no more possibility of any more expansion, at this stage all the 
points have been segregated to a cluster with the given cluster number.  
 
This scan resulting in an initiation followed by expansion process goes on till all the points have 
been visited in the data set with all the points getting their proper designation as being in any of 
the clusters formed with the given density parameters i.e. Npts and Eps or being a noise point. In 
addition to having two compulsory array i.e. VisitArray and ClassArray we can also add a 
TypeArray to keep a tab on the three types of possibilities that a point can exhibit CorePoint, 
BorderPoint or NoisePoint. 
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Figures 
 
 
Figure 16. The STORM imaging process consists of many cycles of activation, imaging and 
deactivation of fluorophores. In each cycle, a small subset of molecules is activated such that the 
images of single molecules (red circles) do not overlap. The position of the each fluorophore is 
determined by finding the center of its image (black crosses). After many cycles of imaging, 
super-resolution image can be reconstructed from the measured positions of the individual 
molecules.  
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Figure 17.  A schematic of the STORM microscope. The microscope is based on an inverted 
microscope. Laser intensities are controlled by passing the laser through a half-wave plate (HW) 
followed by a polarizing beam-splitter (PBS) cube. Different laser lines are combined into a 
single beam using dichroic mirrors (DM). The beam is then expanded 10 times by lenses L1 and 
L2 and focused on the back focal plane of the objective (Obj) using lens L3. L3 is on translation 
stage, which allows adjustment of the incident angle of illumination. The light is detected on the 
charge-coupled device (CCD) camera after passing through a set of bandpass filters (BF) to 
collect emission from specific fluorophores, and notch filters (NF) to block laser lines. A 
cylindirical lens (CL) is used in emission path for astigmatism imaging in 3D STORM. Lenses 
L4 and L5 are used to magnify the image for an additional 1.5 times. CRIFF is used as a focus-
lock system. The position of an infrared (IR) laser that is reflected off the sample-cover-glass 
interface is detected on a quadrant photodiode (QPD). The position of the beam on QPD reports 
motion between the objective lens and the sample, and this signal is fed back to the piezoelectric 
objective (PO), which corrects for the motion. 
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Figure 18. (a) Labeling samples with indirect immunofluorescence for STORM imaging: The 
sample is incubated first with the unlabeled primary antibody that specifically binds the target 
molecule, and then the dual-labeled secondary antibody that binds to the primary antibody (b) 
Absorption spectrum of the dual-labeled secondary antibodies, indicating absorption peaks of the 
antibody, reporter and activator dyes. (c) Confocal image of microtubules (green) and 
mitochondria (red) in HeLa cells, labeled via immunofluorescence. 
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Figure 19. The imaging scheme of a two color STORM experiment. First, red laser is sent to 
the sample to turn off the Alexa Fluor 647 dyes. Violet laser is then briefly applied to switch 
some of the fluorophores to the fluorescent state. We send the red laser to the sample to 
image the activated fluorophores in 3 sequential frames. This is one imaging cycle. We 
repeat the cycle for 20-40 thousand times. After imaging the Alexa Fluor 647 channel, we 
move onto the Alexa Fluor 568 channel to take another for 20-40 thousand frames, for which 
we use yellow laser for imaging, and violet laser for activation. 
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Figure 20. An image frame taken from a STORM movie. (a) The bright spots in the image 
correspond to the fluorescence emission from single fluorophores, which do not overlap. (b) 
An automated peak finding algorithm is used to identify peaks. The identified peaks are 
marked by white circles.  
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Figure 21. Calibration curve generated from distributions of     and    values of images 
of fluorescently labeled single antibodies, as the objective is moved in z direction. 
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Figure 22. Correction of lateral drift in STORM images. (a) STORM image before drift 
correction. (b) Corresponding STORM image after drift correction. The STORM data set is 
divided into a number of equal time segments. STORM image for each segment is generated. 
By calculating the correlation function between STORM images generated from consecutive 
segments, the drift can be determined for that time period. The STORM image can be then 
corrected by subtracting the drift from localizations.   
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Figure 23. Single-color stochastic optical reconstruction microscopy (STORM) imaging of 
microtubules. (a and b) Conventional and STORM images of a region of a BSC-1 cell (c and 
d) Conventional and STORM images of the region identified by the white box.  
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Figure 24. Single-color stochastic optical reconstruction microscopy (STORM) imaging of 
clathrin-coated vesicles. (a and b) Conventional and STORM images of a region of a BSC-1 
cell (c and d) Conventional and STORM images of the region identified by the white box.  
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Figure 25. Two-color stochastic optical reconstruction microscopy (STORM) imaging of (a) 
microtubules and (b) mitochondria (c) overlay of the two channels. 
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Figure 26. RIG-I localize to antiviral stress granules under various stress conditions (a) MEF 
cells that are fixed 12 hours post Poly I:C transfection, and are immunofluorescently stained 
for RIG-I and TIAR. (b) MEF cells are infected with IAVNS1 for 12 hours, treated with 
sodium arsenite for 1 hour, or exposed to heat (44 °C) for 30 minutes. Cells were fixed and 
stained for RIG-I. 
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Figure 27. Stochastic optical reconstruction microscopy (STORM) imaging of RIG-I in 
antiviral stress granules. (a) Conventional image of one antiviral stress granule in an MEF 
cell, 12 hours after poly I:C transfection (b) Corresponding STORM image. 
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Figure 28. RIG-I forms clusters in the antiviral stress granules. (a) STORM image of RIG-I 
in an MEF cell displaying several antiviral stress granules 12 hours after poly I:C transfection 
(b) STORM image of RIG-I in an individual stress granule identified by the white box in a. 
(c) Clusters of RIG-I identified by the DBSCAN cluster analysis program are plotted in 
various colors. (d) STORM image of TIAR in an MEF cell 12 hours after poly I:C 
transfection (b) STORM image of TIAR in an individual stress granule identified by the 
white box in d. (c) Clusters of TIAR identified by the DBSCAN cluster analysis program are 
plotted in various colors.  
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Figure 29. RIG-I forms clusters in the antiviral stress granules. (a) Analysis of percentage of 
RIG-I and TIAR localizations in clusters, in the antiviral stress granules and cytoplasm of 
MEF cells, 12 hours after poly I:C transfection.  (b) Analysis of cluster sizes of RIG-I and 
TIAR in the antiviral stress granules and cytoplasm of MEF cells, 12 hours after poly I:C 
transfection. 
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Figure 30. RIG-I forms clusters in the antiviral stress granules under various stress 
conditions. (a) STORM image of RIG-I in antiviral stress granules in MEF cells 12 hours 
after IAVNS1 infection, 1 hour after sodium arsenite treatment or 30 min after heat shock 
(44 °C). (b) Analysis of percentage of RIG-I localizations in clusters, in antiviral stress 
granules of MEF cells, 12 hours after IAVNS1 infection, 1 hour after sodium arsenite 
treatment, or 30 minutes after heat shock (44 °C). (c) Analysis of cluster sizes of RIG-I in the 
antiviral stress granules of MEF cells, 12 hours after IAVNS1 infection, 1 hour after 
sodium arsenite treatment, or 30 minutes after heat shock (44 °C) 
.   
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Chapter 4 
Analysis of Genome Composition of 
Influenza A Virus at the Single Virus 
Particle Level
‡
 
Introduction 
Influenza viruses possess a lipid envelope which harbors the glycoproteins hemagglutinin (HA), 
neuraminidase (NA) and the matrix protein 2 (M2). The core of the virus is comprised of viral 
ribonucleoprotein complexes (RNPs) consisting of viral RNAs, nucleoproteins (NP) and three 
RNA polymerase proteins (PB2, PB1 and PA). The virus genome is composed of 8 negative-
sense, single-stranded RNA segments: namely PB2, PB1, PA, NP, HA, NA, M and NS. One of 
the critical steps in influenza virus infection is the packaging of its segmented genome into the 
budding virions 
1
. The segmented genome confers an evolutionary advantage that allows the 
genes from different virus strains to shuffle and reassort, creating progeny viruses with unique 
characteristics 
2, 3
. However, this segmented nature of viral RNA also complicates the process of 
genome packaging because at least one complete set of eight viral RNA segments has to be 
packaged into a virus particle to produce infectious progeny. The mechanism by which influenza 
virus ensure correct packaging of its genome is still unclear.  
Two models have been proposed for the incorporation of influenza viral RNAs: the random 
incorporation model 
4, 5
 and the selective incorporation model 
6-13
.   The random incorporation 
model proposes that a sufficient number of viral RNAs are randomly chosen to be packaged that 
will give a reasonable proportion of viable virions that contain at least one copy of each RNA 
segment 
14
. The selective incorporation model suggests that a virus particle packages no more 
                                                          
‡
 This work has been published as a paper: 
 Chou, Y.Y., R. Vafabakhsh, S. Doğanay, Q. Gao, T. Ha and P. Palese, "One influenza virus particle 
packages eight unique viral RNAs as shown by FISH analysis", PNAS 109, 9101-9106 (2012). 
 Gao, Q., Y. Y. Chou, S. Doganay, R. Vafabakhsh, T. Ha and P. Palese, "The influenza A virus PB2, PA, 
NP and M segments play a pivotal  role during genome packaging", J. Virology  86, 7043-7051 (2012). 
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than eight viral RNPs and each viral RNA segment contains unique features which allow the 
viral RNAs to be recognized and distinguished from other segments. The latter being the 
currently favored hypothesis is supported by: (1) EM analyses showing budding virions 
incorporating eight viral RNPs arranged in a “7+1” architecture 15-18 and (2) Segment-specific 
packaging sequences located at the terminal ends of all eight viral RNAs had been identified by 
virtue of reverse genetics 
6, 8, 10, 11, 19, 20
. Even though there has been growing evidence supporting 
the selective packaging method, conclusive proof that the eight viral RNPs observed in a 
budding virion are each different is still lacking. Earlier studies using electrophoresis of RNA 
showed that viral segments were presented at an approximately equal molar ratio within a 
purified virus preparation 
21, 22
 but no study has been done to determine how the incorporated 
viral segments were segregated into individual virus particles.  Recent studies using electron 
tomography showed the viral RNPs incorporated in the budding virions possess different lengths, 
however, only a few virus particles were analyzed and the segments with similar length could not 
be differentiated by this method 
15, 23
. The development of single-particle approaches has allowed 
the characterization of virus particles and events in the virus life cycle which might have been 
missed in the observations of the entire virus population 
24-26
.  Therefore, to study the genome 
packaging of influenza viruses, new methods which allow stoichiometric analysis of viral RNAs 
within single virus particles with individual RNA sensitivity are required. 
Herein, we have designed a novel scheme which allows the detection and quantification of the 
viral RNAs within influenza virions at single-virus resolution. We applied the single-molecule 
fluorescence in situ hybridization (smFISH) technique 
27
 to surface immobilized virus particles 
to quantify the packaged viral RNAs. With this new approach, we have shown that most if not all 
influenza virus particles package heterogeneous viral RNAs and each viral RNA segment was 
packaged only once. These data provide direct evidence that the packaging mechanism in the 
influenza virus is very robust and the majority of  virus particles package the unique eight viral 
RNAs.  
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Experimental Results 
FISH analysis at single virus particle level 
We used prism-type total internal reflection fluorescence microscopy (TIRF)
28
 to study 
individual virus particles immobilized on the slide surface. To abolish non-specific attachment of 
virus particles, the slide surface was passivated with an inert polymer (PEG) sparsely doped with 
biotinylated polymer. Virus particles were immobilized on the surface through biotinylated 
antibodies against the influenza hemagglutinin (HA) protein which were attached to NeutrAvidin 
molecules specifically bound to biotinylated polymers on the surface (Fig.31.A). In order to 
quantify the viral RNA composition of virus particles, we performed smFISH on virus particles 
immobilized on the microscope slides 
29
. Since viral RNAs are packaged within the virus 
envelope, the immobilized virus particles were fixed with 4% paraformaldehyde and the viral 
membrane was then permeabilized with 0.25% Triton-X 100. FISH DNA probes, each labeled 
with one fluorophore, were used to hybridize to the specific target RNA. We first validated the 
assay by immobilizing influenza A/Puerto Rico/8/34 (PR8) virus and performing smFISH using 
a mixture of 48 Cy3 labeled probes against the NA or 48 Cy5 labeled probes against the PB2 
RNA segments. In each case more than 150 fluorescent spots were detected. On the other hand, 
control experiments using probes against a non-influenza RNA gene (RIG-I) or blank slides 
showed very few dim spots (Fig 31.B, C). Since the experiments were performed on different 
channels of the same passivated slide and the concentrations of the antibody, virus particles and 
each probe were kept the same, we expected that similar density of virus particles were 
immobilized on the surface for each experiment. Therefore, the reproducible large contrast in the 
number of spots (about 2 orders of magnitude) observed between control experiments and 
experiments probing for influenza viral RNAs showed the high specificity of smFISH in 
detecting viral RNA segments.  
One influenza virus particle efficiently co-packages viral RNAs of different identities 
Having established the platform for FISH analysis at single-virus particle resolution, we 
determined the co-packaging efficiency of two different viral RNA segments into virions by 
performing hybridization with two probe sets targeting different viral RNAs, one probe set 
labeled with Cy3 fluorophores and the other labeled with Cy5 fluorophores. Two differently 
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labeled probe-sets (Cy3 and Cy5) targeting two different regions of the same viral RNA were 
used as positive controls and demonstrated the specificity of our technique (Fig.32.A). The two 
sets of probes against different regions of the NA segments showed over 90% (93.1% ±2.2% ) 
colocalization between Cy3 and Cy5 spots and 84.8%±2.0% colocalization for probes against the 
M segment.  The percentages of spots showing only Cy3 or Cy5 signals were comparable and 
were all below 10% in both cases, indicating that the two differently labeled probe sets share 
similar sensitivity and detect comparable number of viral RNAs (Fig.32.B). While we observed 
similar intensity distributions between colocalized spots and spots that do not colocalized, 
intrinsic defects of some virus particles or the limitation of our detection and analysis would 
explain why we did not see 100% co-localization between the Cy3 and Cy5 fluorescence spots. 
To understand if influenza virus efficiently packages viral RNA of different identities, we first 
tested the co-packaging efficiency of the Cy3 probe labeled PB2 segment paired with the other 
seven viral RNA segments that were labeled with Cy5 probes. Colocalizataion efficiency was 
calculated as the number of colocalized spots over the number of Cy3 fluorescent spots 
corresponding to the PB2 segment. The PB2 segment showed high percentages of colocalization 
with all the other viral RNA tested (Fig. 32.C). These results demonstrated that the PB2 segment 
was efficiently co-packaged with other viral RNAs into virus particles and over 50% of virus 
particles that package the PB2 segments also package the other seven segments. This percentage 
comes from multiplying the colocalization efficiencies of viral segments paired with the PB2 
segment (0.911×0.944×0.922×0.9×0.889×0.9×0.9). In all these experiments, the Cy5 probes 
targeting the paired viral RNAs detect comparable number of spots as the Cy3 probes against the 
PB2 segment. This also results in high percentages of a particular gene that co-packaged with the 
PB2 segments suggesting that other gene segments efficiently co-packaged with the PB2 
segment as well (Fig. 35).   Colocalization analysis of the PB1 segment with the NA segment 
and the M segment also showed percentages of colocalization over 90% (97.0%±1.86% for PB1 
and NA, 95.4%±2.93% for PB1 and M) (Fig. 32.D). These data show that influenza virus 
proficiently packages heterogeneous viral RNAs into virons. 
One copy of each viral RNA segment is packaged into a virus particle 
In order to understand if the heterogeneous viral RNAs packaged into the virus particles were 
unique, we determined the copy number of each viral RNA segment being packaged. If a viral 
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RNA segment is unique in the virus particle, only one copy of that RNA would be detected by 
the single-virus particle FISH analysis. The number of viral RNAs being packaged can be 
determined by counting the number of hybridized probes in a fluorescent spot by photobleaching 
analysis.  
We first performed single-virus particle FISH and photobleaching analysis on the HA viral RNA 
segment in the PR8 virus. In this experiment, 15 HA targeting probes singly labeled with Cy5 
were mixed for hybridization. Movies of several imaging areas were obtained and the time traces 
of fluorescence intensity for the spots were analyzed.  As the fluorophore on each probe 
photobleaches over time, the fluorescence intensity diminishes over time, yielding a step-wise 
profile. The number of steps corresponds to the number of probes that are hybridized to the HA 
target (Fig. 33.A). Since 15 probes were used for hybridization and the binding efficiencies of 
the probes were different, the number of probes bound to a single viral RNA would not be 
identical. To address this question, we counted the number of photobleaching steps for over 800 
fluorescent spots corresponding to the HA viral RNA. Figure 3D shows the distribution of the 
number of photobleaching steps for FISH probes against the HA viral RNA in the PR8 virus 
particles. A single peak around 7 steps was observed, demonstrating that on average 7 probes are 
likely to hybridize with an HA viral segment in a single virus particle using our experimental 
design. In addition, particles displaying more than 15 photobleaching steps were observed and 
because a maximum of 15 probes can be hybridized to one viral RNA segment, these particles 
likely represent aggregates of virus particles or virus particles containing multiple targeted viral 
RNAs.   
In order to demonstrate that PR8 virus particles package only one copy of the HA segment 
instead of two or more copies, we utilized reverse genetic techniques to generate a virus that 
carries two copies of the HA gene. It has been shown previously that influenza viral RNAs 
possess segment specific packaging sequences governing the incorporation of viral RNAs into 
the virions. A recombinant virus carrying one additional segment had been successfully 
generated by engineering the segment specific packaging sequences in the viral genome 
30
 . 
Applying the same principle, we exchanged the packaging signals for the PB2 segment with the 
NA segment-specific packaging signals and the packaging sequences that remained within the 
PB2 open reading frame were inactivated with serial synonymous mutations (NA-PB2mut-NA 
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segment). The PB2 packaging signals were then used to flank the additional HA open reading 
frame, which also contained serial silent mutations at both terminals to inactivate the residual 
packaging sequences (PB2-HAmut-PB2 segment) (Fig. 33.B). The 2HA-PR8 virus carries the 
mutated PB2 segment and two HA segments. To determine if both HA segments were 
incorporated into the virus particles, viral RNA extracted from purified 2HA-PR8 virus was 
resolved using RNA electrophoresis followed by silver staining. The PB2-HAmut-PB2 segment 
migrating between the PA segment and the HA segment was observed, showing that the 
additional HA segment was incorporated into virus particles. The intensity of the band was 
similar between wild type HA segment and the PB2-HAmut-PB2 segment, suggesting that both 
segments were incorporated into virus particles at comparable efficiency (Fig 33.C). It is of note 
that the NA-PB2mut-NA segment was not resolved by RNA electrophoresis demonstrating that a 
low number of virus particles package this segment.  Taken together, these data suggest that a 
virus population incorporated two segments containing the HA open reading frame existed in the 
2HA-PR8 virus. 
To test if the photobleaching analysis is able to resolve the number of target segments packaged 
into virus particles, we performed FISH and photobleaching analysis on 2HA-PR8 virus under 
the same experimental conditions as the wild type. The histogram of photobleaching steps for the 
HA segment in the 2HA-PR8 virus showed an increased breadth of the overall curve than for the 
HA segment in the wild type PR8 virus, indicating that the photobleaching analysis was able to 
detect differences in the number of target segments packaged into virus particles. Two peaks 
were observed in the histogram of the HA segment in 2HA-PR8 virus, the first peak occurred 
around 7 steps which was the same peak step number as for the PR8 virus. The second peak 
appeared around 13 steps, which is approximately double the step number of the first peak. 
These results showed that in the 2HA-PR8 virus population, there were some virions containing 
the same number of HA segment as the wild type PR8 virus and some virus particles that 
packaged as twice as many. To further confirm that the 2HA-PR8 virus did not exhibit intrinsic 
disorganization of viral RNA packaging, we performed FISH and photobleaching analysis using 
15 Cy5 probes against the NP segment in the wild type PR8 and 2HA-PR8 virus. The 
photobleaching step histograms of NP segment in both viruses displayed single peak 
distributions, demonstrating that 2HA-PR8 virus was not defective in packaging other viral 
RNAs and the stoichiometry of the packaged NP segment was the same as that of the wild type 
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virus (Fig.33E). Since it was unlikely that a 2HA-PR8 virus packaged 4 copies or more HA 
segments, these data strongly suggested that the double peak distribution seen was representative 
of 2 viral HA segments being incorporated into a single virion. Therefore, the single peak 
distribution of the photobleaching step histogram seen for the HA segment in PR8 virus arguably 
represents only one copy of the HA segment packaged into virus particles.  Our data also 
strongly suggests that a single copy of NP is incorporated into a single virion. 
We next wanted to assess whether only a single copy of the other viral RNA segments were 
package into PR8 virus particles. We performed FISH and photobleaching step analysis for the 
other six segments: PB2, PB1, PA, NA, M and NS. For each viral segment analyzed, 15 Cy5 
probes were mixed for the hybridization reaction and bleaching steps for more than 500 
fluorescence spots were counted. The histograms of the photobleaching steps for the segments 
examined all exhibited single peak profiles (Fig. 34). Based on the distribution of the number of 
photobleaching steps and Gaussian fit curves of the histograms, it is estimated that for each viral 
RNA segment a single copy of the segments are packaged into over 90% of the virus particles 
(Fig. 36). These results demonstrated that for each viral RNA segment, a single copy of segment 
was packaged into a virus particle. Because a high proportion of influenza virus particles 
package 8 different viral RNA segments (Fig. 32) and each segment was packaged with the same 
copy number, these results provided strong evidence that the majority of influenza virus particles 
contain one copy of each viral segment. 
In conclusion, we have demonstrated with the two-color FISH and photobleaching step analysis 
on individual virus particles that a large proportion of virus particles packaged heterogeneous 
viral RNPs and a single copy of each gene was packaged into a virion in most cases. Therefore, 
we have provided evidence that an influenza virus particle packages eight unique viral RNAs and 
this selective packaging process is efficient. 
Discussion 
In this study, we have established an experimental system assay based on smFISH to study the 
packaged RNA compositions in individual virus particles. Our results demonstrate that eight 
unique viral RNAs are packaged within a single influenza virion.     This technique created a 
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powerful tool to understand the stoichiometry of viral RNAs inside virus particles and provided 
quantitative data on the subpopulations of different viruses.  
In this report, two-color FISH analysis on virus particles provided direct measurements of the 
probability of two different viral RNA segments being co-packaged into the same virion. The 
PB2 segment was shown to be co-packaged with each of the other viral RNA segments at 
efficiencies around 90%. This indicated that a large proportion of virions that package the PB2 
segment also package the other seven segments.  It is of note, however, that colocalization 
between Cy3 and Cy5 in our control experiments was only approximately 90% (Fig.32. B). 
Because we would expect the controls to have 100% colocalization, it is possible that we are 
underestimating the percentage of virions that incorporate all 8 segments.  Nevertheless, these 
results quantitatively showed that heterogeneous viral RNA segments are selectively packaged 
within an influenza virion with high efficiency.  
The precise mechanisms and viral elements essential for the selection process are largely 
unknown. Segment-specific packaging sequences have been discovered for all eight viral RNA 
segments by virtue of reverse genetics and mutation analysis 
6-9, 11, 19, 20
. Several studies have 
shown that mutations introduced into the packaging signals of one segment of a viable virus 
affects the incorporation of that segment into virions as well as the incorporation of other 
segments to different degrees 
6, 8, 19
. For example, synonymous mutations introduced into the HA 
packaging sequences reduced the incorporation of not only the HA segment but also of the PB2 
segment, as shown by quantitative-PCR of viral RNAs extracted from viruses 
8
. These studies 
have demonstrated that there are interactions amongst different viral RNA segments that could 
affect their incorporations into virus particles, however, there have not yet been studies to assess 
the role that packaging signals, or general interactions amongst viral genes, play in the co-
packaging of different viral RNA segments. With this new technology, we were able to quantify 
the numbers of virus particles containing two different viral RNA segments, allowing for the 
calculation of the probability of these two segments being co-packaged. This experimental setup 
provided a new measurable parameter for influenza virus and can be further applied to study the 
effect of identified packaging signals on the co-packaging efficiency of viral RNAs or the 
discovery of new viral elements governing the selective packaging process.  
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The selection process of influenza viral RNA packaging was controlled not only for the identities 
of the segments packaged but also for their copy number. We have applied photobleaching 
analysis to resolve the copy number of a specific viral RNA segment that is packaged into one 
virion. Results from the analysis of the HA segment in wild type PR8 and 2HA-PR8 viruses 
showed that only one copy of the HA segment was incorporated per PR8 virus particle. Analysis 
of other viral RNA segments also suggested that eight single copy of each viral RNA segment 
was packaged into one virus particleIt is of note, however, aggregations of up to 10% of the virus 
particles or immobilization of two virus particles within diffraction limited area could happened 
in the photobleaching analysis experiments (Fig. 33&34), resulting in an underestimation of the 
percentages of virus particles containing single copy of a viral RNA (Fig. 36). Thus, the 
percentage of virus particles containing single copy of a specific gene is close to 100% and the 
percentage of virus particles that package eight single copy of each of the eight viral RNA is 
much higher than the estimated 40% (0.9^8) (Fig. 36). These data, together with earlier studies 
showing that the eight segments exhibited approximately equal molar ratio in RNA extracted 
from purified viruses 
22
, strongly suggest that each of the eight viral RNA segments are equally 
distributed into individual virus particles.  Given that EM analyses have shown budding 
influenza virions with eight viral RNPs 
15, 16, 23
 and the data presented here showing high co-
packaging efficiency of heterogeneous viral RNA segments (Fig. 32), we believe that in more 
than one third of the virus population, one copy of each of the eight viral RNA segments is 
indeed packaged into one influenza virus particle. 
In conclusion, we have established a new experimental system for single-molecule sensitivity 
FISH analysis on individual virus particles. This technique allowed us to understand the 
stoichiometry and composition of the segmented viral RNAs in influenza virus particles. We 
have shown with this technique that one influenza virus particle packages eight unique viral 
RNA segments, providing quantitative evidence that the genome packaging of influenza virus is 
a highly selective process. This novel strategy can be further applied to study the packaging 
mechanisms of other viruses with a segmented genome.    
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Experimental Procedures 
Cell and viruses 
293T cells were obtained from the American Type Culture Collection (ATCC, Manassas, VA) 
and were maintained in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf 
serum. The influenza A/Puerto Rico/8/34 (PR8) virus and the recombinant 2HA-PR8 virus were 
grown in 10-day-old specific-pathogen-free chicken embryos (Charles River Laboratories, 
SPAFAS, Preston, CT).  
Plasmid construction.  (i) Generation of PB2-HAmut-PB2 construct.  The GFP open reading 
frame from a previously made PB2-GFP-PB2 construct 
30
 was replaced with the PR8 virus HA 
open reading frame carrying serial silent mutations on the two ends [named as HAmut, see 
reference 
31
], generating the PB2-HAmut-PB2 construct.  Nhe I and Xho I restriction sites were 
used for cloning.  (ii)  The NA-PB2mut-NA construct was described previously 
30
. 
Reverse genetics for the 2-HA PR8 virus 
Generating recombinant 2-HA PR8 virus was performed using previously described methods
30
  
Virus purification 
Wild type PR8 virus and the 2-HA PR8 virus were grown in 10-day embryonated chicken eggs 
(Charles River Laboratories, SPAFAS) at 37°C for 48 hours and 60 hours, respectively. The 
embryos were then killed and the allantoic fluid was harvested. The allantoic fluid was clarified 
by centrifugation at 4000rpm at 4°C for 30 minutes. The clarified allantoic fluid was then layered 
on a 20% sucrose cushion and centrifuged at 4°C, 25000rpm for 2 hours using a Beckman rotor 
SW28. The pelleted virus was resuspended in 1XNTE buffer (100 mM NaCl, 10mM Tris-HCl  
pH 7.4, 1mM EDTA )and layered onto a 10%-30% iodixanol density gradient (Sigmal-Aldrich, 
MO) for centrifugation at 25000 rpm for 3 hours at 4°C. The virus was extracted from the 
gradient using a syringe and pelleted by centrifugation at 4°C, 25000rpm for 1.5 hours. The 
purified virus was resuspended in 1XNTE and stored at -80°C before use. 
Polyacrylamide agarose gel electrophoresis for purified viral RNA 
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The viral RNA for gel electrophoresis was extracted from purified viruses using TRIzol reagent 
(Invitrogen) following methods that were previously described 
32
.  
Single virus particle immobilization and fluorescence in situ hybridization  
Virus particle immobilization and single-molecule imaging were performed as previously 
described 
29
 with several modifications. In brief, flow chambers were prepared on polyethylene 
glycol (PEG) passivated slides doped with biotinylated PEG and coated with NeutrAvidin 
(Thermo). To capture influenza virus particles, biotinylated mouse-monoclonal anti-
hemagglutinin antibodies were immobilized by incubating the antibody at a 15 nM concentration 
on the chambers for 20 minutes at room temperature. The virus was diluted in T50 buffer (10mM 
Tris-HCl, pH 8.0, 1mM EDTA, 50mM NaCl) and incubated for 30 minutes at room temperature 
over the surface with immobilized antibody. The PR8 virus was diluted 1:150 and the 2-HA PR8 
virus was diluted 1:30 from the stock to obtain well-isolated spots on the surface (~250 particles 
in 2500 µm
2
 imaging area). The unbound antibodies and virus particles were washed away with 
T50 buffer. The antibodies and virus were then fixed with 4% paraformaldehyde in T50 buffer 
for 10 minutes. After one wash with T50 buffer, the virus particles were permeablized by 10 
minutes incubation with 0.25% Triton X-100 to expose the viral RNPs. The flow chambers were 
then washed twice with T50 supplemented with 2mM RNase inhibitor vanadyl ribonucleoside 
complexes (VRC) (New England BioLabs) before hybridization. 
Fluorescence in situ hybridization was performed following protocols published earlier 
27, 33
. For 
each influenza viral RNA, 30-48 probes were designed and synthesized (Biosearch technologies, 
Novato, CA). The probes were labeled with Cy3 or Cy5 fluorophores and HPLC purified 
according to published protocol 
34
. The hybridization reactions were carried out by incubating 
the permeabilized virus with the hybridization solution containing each probe at a 4 nM 
concentration at 37°C for 3 hours. Different numbers of probes were mixed for the hybridization 
reactions according to experimental purposes. After hybridization, the virus immobilized 
surfaces were washed with wash buffer (2X SSC, 10% formamide and 2mM VRC) at 37°C for 
30 minutes and then incubated in 2XSSC before imaging. Single-molecule imaging was 
performed using a prism type total internal reflection fluorescence (TIRF) microscope and the 
single molecule analysis was performed as earlier described 
28, 29
.  
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Photobleaching step analysis 
The single-molecule fluorescence time traces of the hybridized viral RNAs were scored for the 
number of photobleaching steps by a semi-automated algorithm. As clean bleaching steps could 
be identified, the average step size of a single bleaching step was calculated and the total number 
of photobleaching steps was determined based on the starting fluorescence intensity. All the 
fluorescence traces were examined manually, traces with no clean bleaching steps or derived 
from fluorescent spots exhibiting oval shape (virus particles aggregates) were discarded. For 
each sample, at least 300 particles were scored. 
Colocalization analysis 
Colocalization between Cy3 and Cy5 spots was analyzed similarly as previously described 
29, 35
. 
The colocalization efficiency was calculated as the overlap percentage of the number of 
colocalized spots over the total number of Cy3 spots. 
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Figures  
 
Figure 31. A. Schematic for fluorescence in situ hybridization analysis on single virus particle. 
Viral RNA hybridized with multiple fluorophore-labeled probes is visualized using total internal 
reflection fluorescence (TIRF) microscopy.  Biotinylated antibodies against the influenza virus 
surface protein HA are immobilized on imaging surface passivated with polyethylene glycol 
(PEG) and doped with biotinylated PEG and NeutrAvidin. Influenza virus particles are captured 
onto the imaging surface with the immobilized anti-HA antibodies. FISH is performed on virus 
particles that are captured, fixed and permeabilized on the imaging surface. B. TIRF images of 
FISH signals from hybridization reactions using a mixture of 48 DNA probes singly labeled with 
fluorophores targeting viral RNA on a blank slide (no immobilized virus), PR8 virus-
immobilized slides and FISH signals from hybridization reactions on PR8 virus-immobilized  
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Continued Figure 31. 
slide using 48 Cy3-labled probes against the RIG-I mRNA are shown.  C. Average number of 
fluorescent spots per 1000 μm2 is shown (number of fields,  n>10).  
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Figure 32. Co-packaging of different viral RNA segments into a virus particle. A. One set of 
representative TIRF images for colocalization analysis is shown here. Immobilized PR8 virus 
particles were hybridized with 23 Cy3-labeled probes and 23 Cy5-labeled probes against the 
viral RNA NA segment. The Cy3 and Cy5 probe sets were targeting distinct regions of the NA 
segment. TIRF images of particles labeled with Cy3 probes and Cy5 probes are shown. The  
93 
 
 
Continued Figure 32.  
overlay image of the two images is shown to the right. Scale bar= 5µm.  B. Colocalization 
efficiency of two fluorescence probe sets targeting the same viral RNA. FISH analyses were 
carried out on PR8 virus immobilized imaging surfaces using 23 Cy3-labeled probes and 23 
Cy5-labeled probes against the NA viral segments or 16 Cy3-labeled probes and 16 Cy5-labeled 
probes against the M viral segments. The percentages of the number of the Cy3-only spots, the 
Cy5-only spots and the dual-labeled spots over the total number of spots are plotted. C. 
Colocalization efficiency of the PB2 segment with the PB1, PA, HA, NP, NA, M and NS 
segment is shown. For each pair with the PB2 segment tested, 48 Cy3-labeled probes targeting 
the PB2 segment were mixed with 15 Cy5-labeled probes targeting the paired segment. D. 
Colocalization efficiency of the PB1 segment with the NA and M segment. FISH analysis was 
performed by mixing 48 Cy3-labeled probes targeting the PB1 segment with 15 Cy5-labeled 
probes targeting either the NA or M segments. The colocalization efficiency is calculated as the 
number of Cy3 and Cy5 colocalized spots over the total number of Cy3 spots. The data shown 
are normalized by setting the colocalization efficiency of Cy3 and Cy5 probe sets against the NA 
segment as 100% (see Figure 32B). Error bars denotes standard deviation (s.d), n>10.  
  
94 
 
 
Figure 33. PR8 virus particle packages one copy of the HA segment . A. Photobleaching 
analysis of the HA viral RNA in PR8 viruses hybridized with 15 Cy5-labeled probes. The image 
shown on the right is an average of 30,000 TIRF movie frames of a short movie taken at an 
imaging area which was consistently excited for 5 minutes. A typical plot of total fluorescence 
intensity versus time for a Cy5 spot exhibiting a seven–step photobleaching behavior is shown to  
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Continued Figure 33.  
the right. This plot is corresponding to the circled spots in the averaged TIRF image.   B. 
Genome structure of the 2HA-PR8 virus. Seven A/Puerto Rico/8/34 ambisense plasmids (pDZ-
PB1, pDZ-PA, pDZ-HA, pDZ-NP, pDZ-NA, pDZ-M, pDZ-NS) and two chimeric constructs 
pDZ-NA-PB2mut-NA and pDZ-PB2-HAmut-PB2 (see material and methods) were used to 
generate the 2HA-PR8 virus by reverse genetics. C. Analysis of viral RNA packaging in 2HA-
PR8 virus. Purified viral RNAs from the 2HA-PR8 virus and PR8 virus were resolved using a 
2.8% acrylamide gel followed by silver staining. The identities of the bands were labeled based 
on their sizes and previous findings. D. Histogram of the photobeaching steps analyzed for the 
FISH probes hybridized HA segment in PR8 and 2HA-PR8 viruses. Error bars denote standard 
deviations. n≥5.  E. Histogram of the photobleaching steps analyzed for the FISH probes 
hybridized NP viral RNA in PR8 virus and 2HA-PR8 virus. The black squares and solid black 
lines represent the PR8 virus and the red squares and solid red lines represent the 2HA-PR8 
virus. Error bars denote standard deviations. n≥3.  
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Figure 34. PR8 virus packages single copy of each viral RNA segment. Histograms of the 
photobleaching analysis are shown for the PB2 (A), PB1 (B), PA(C), NA (D), M (E) and NS (F) 
segments in the PR8 virus. Error bars denote standard deviations. n≥3. 
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Figure 35. The colocalization efficiency of the PB2 segment with the PB1, PA, NP, NA, M, or 
NS segment (no. of colocalized spots/no. of PB2 spots) and the colocalization efficiency of PB1, 
PA, NP, NA, M, or NS with the PB2 segment (no. of colocalized spots/no. of PB2 spots) are 
shown. 
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Figure 36. Double-Gaussian fit to the histograms of the number of photobleaching steps. (A) 
Double-Gaussian fit to the histogram of the photobleaching steps analyzed for the FISH probes 
hybridized with the PA viral RNA. The red curve represents Gaussian fit to the main peak and 
shows 90% of the population contains a single copy of the viral RNA. (B) Double-Gaussian fit to 
the average histogram. This histogram was obtained by averaging the PB2, PB1, M, NP, and PA 
photobleaching histograms normalized to their peak positions. The red curve represents Gaussian 
fit to the main peak and shows 91% of the population contains one copy of a specific viral RNA. 
The green curves are Gaussian fits to the second peaks and the blue curves are the overall fits 
overlaid on the histograms. 
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